Difference between revisions of "LncRNAWiki:Featured"
Chunlei Yu (talk | contribs) |
|||
Line 5: | Line 5: | ||
!Alias | !Alias | ||
!Description | !Description | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''21A'' | |''21A'' | ||
Line 30: | Line 20: | ||
|7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | |7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | ||
|RNA, 7SL, cytoplasmic 1 | |RNA, 7SL, cytoplasmic 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ABALON'' | |''ABALON'' | ||
Line 41: | Line 26: | ||
|apoptotic BCL2L1-antisense long non-coding RNA | |apoptotic BCL2L1-antisense long non-coding RNA | ||
|- | |- | ||
− | |'' | + | |''AIRN'' |
− | |[[ | + | |[[ENST00000609176.1]] |
− | | | + | |AIRN, AIRN, IGF2RAS |
− | | | + | |Antisense of IGF2R non-protein coding RNA |
|- | |- | ||
− | |'' | + | |''APOA1-AS'' |
− | |[[ | + | |[[ENST00000444200.1]] |
− | | | + | |APOA1 antisense RNA |
− | | | + | |N/A |
|- | |- | ||
− | |'' | + | |''APTR'' |
− | |[[ | + | |[[NONHSAT121673]] |
− | | | + | |Alu-mediated CDKN1A/p21 |
− | | | + | |N/A |
|- | |- | ||
− | |'' | + | |''BANCR'' |
− | |[[ | + | |[[Lnc-APBA1-3:1]] |
− | | | + | |LINC00586 |
− | | | + | |BRAF-activated non-protein coding RNA |
|- | |- | ||
− | |'' | + | |''BDNF-AS'' |
− | |[[ | + | |[[ENST00000499008.3]] |
− | | | + | |BDNF antisense RNA |
− | | | + | |BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049 |
|- | |- | ||
− | |'' | + | |''BLACAT1'' |
− | |[[ | + | |[[BLACAT1]] |
− | | | + | |linc-UBC1,LINC00912, onco-lncRNA-30 |
− | | | + | |bladder cancer associated transcript 1 (non-protein coding) |
|- | |- | ||
− | |'' | + | |''CAHM'' |
− | |[[ | + | |[[ENST00000604200.1]] |
− | | | + | |LINC00468 |
− | | | + | |colon adenocarcinoma hypermethylated (non-protein coding) |
|- | |- | ||
− | |'' | + | |''PTCSC1'' |
− | |[[ | + | |[[NONHSAT129210]] |
− | | | + | |AK023948 |
− | | | + | |papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) |
|- | |- | ||
− | |'' | + | |''BCYRN1'' |
− | |[[ | + | |[[lnc-EPCAM-1:2]] |
− | | | + | |BC200,BC200a, NCRNA00004, LINC00004 |
− | | | + | |BCYRN1, brain cytoplasmic RNA 1 |
+ | |- | ||
+ | |''BPESC1'' | ||
+ | |[[ENST00000418282.1]] | ||
+ | |NCRNA00187 | ||
+ | |blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding) | ||
+ | |- | ||
+ | |''CYP4A22-AS1'' | ||
+ | |[[ENST00000444042.2]] | ||
+ | |Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506 | ||
+ | |CYP4A22 antisense RNA 1 | ||
|- | |- | ||
− | |'' | + | |''CASC8'' |
− | |[[ | + | |[[CASC8]] |
− | | | + | |LINC00860,CARLo-1 |
− | | | + | |cancer susceptibility candidate 8 (non-protein coding) |
|- | |- | ||
− | |'' | + | |''CCAT1'' |
− | |[[ | + | |[[NONHSAT129017]] |
− | | | + | |CARLo-5, onco-lncRNA-40 |
− | | | + | |colon cancer associated transcript 1 (non-protein coding) |
|- | |- | ||
− | |'' | + | |''CCAT2'' |
− | |[[ | + | |[[CCAT2]] |
− | | | + | |NCCP1, LINC00873 |
− | |N/A | + | |colon cancer associated transcript 2 (non-protein coding) |
+ | |- | ||
+ | |''CISTR'' | ||
+ | |[[NONHSAT028496]] | ||
+ | |CISTR-ACT, CISTRACT, re52431 | ||
+ | |chondrogenesis-associated transcript | ||
+ | |- | ||
+ | |''CRNDE'' | ||
+ | |[[Lnc-IRX3-4:2]] | ||
+ | |LOC643911, LINC00180, CRNDEP | ||
+ | |colorectal neoplasia differentially expressed (non-protein coding) | ||
+ | |- | ||
+ | |''CYYR1-AS1'' | ||
+ | |[[ENST00000357401.3]] | ||
+ | |cysteine and tyrosine rich 1 antisense RNA 1 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''DALIR'' | ||
+ | |[[DALIR]] | ||
+ | |DALI | ||
+ | |DNMT1-associated long intergenic non-coding RNA | ||
+ | |- | ||
+ | |''DANCR'' | ||
+ | |[[NONHSAT096369]] | ||
+ | |differentiation antagonizing non-protein coding RNA | ||
+ | |ANCR, AGU2, lncRNA-ANCR | ||
+ | |- | ||
+ | |''DBET'' | ||
+ | |[[NONHSAT099821]] | ||
+ | |DBE-T, DUX4L30 | ||
+ | |D4Z4 binding element transcript (non-protein coding) | ||
+ | |- | ||
+ | |''DHFR upstream transcripts'' | ||
+ | |[[NONHSAT102417]] | ||
+ | | DHFR minor transcript 5'-UTR, ENSG00000228716 | ||
+ | | N/A | ||
+ | |- | ||
+ | |''DHRS4-AS1'' | ||
+ | |[[NONHSAT035954]] | ||
+ | |DHRS4 antisense RNA 1 | ||
+ | |PRO1488,AS1DHRS4 | ||
+ | |- | ||
+ | |''DLEU1'' | ||
+ | |[[NONHSAT033797]] | ||
+ | |deleted in lymphocytic leukemia 1 (non-protein coding) | ||
+ | |LEU1, XTP6, NCRNA00021, LINC00021, BCMS1 | ||
+ | |- | ||
+ | |''DLEU2'' | ||
+ | |[[NONHSAT033821]] | ||
+ | |deleted in lymphocytic leukemia 2 (non-protein coding) | ||
+ | |LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG | ||
+ | |- | ||
+ | |''DISC2'' | ||
+ | |[[NONHSAT010191]] | ||
+ | |DISC1-AS1, DISC1OS, NCRNA00015 | ||
+ | |disrupted in schizophrenia 2 (non-protein coding) | ||
+ | |- | ||
+ | |''EGOT'' | ||
+ | |[[NONHSAT087635]] | ||
+ | |EGO, "eosinophil granule ontogeny", NCRNA00190, "non-protein coding RNA 190", ENSG00000235947 | ||
+ | |Eosinophil granule ontogeny (EGO) RNA | ||
+ | |- | ||
+ | |''EMX2OS'' | ||
+ | |[[lnc-PDZD8-3:1]] | ||
+ | |EMX2-AS1, NCRNA00045, "non-protein coding RNA 45",ENSG00000229847 | ||
+ | |Emx2 opposite strand transcript. | ||
+ | |- | ||
+ | |''ERICD'' | ||
+ | |[[Lnc-CHRAC1-2:1]] | ||
+ | |TCONS_00014875, ERIC | ||
+ | |E2F1-regulated inhibitor of cell death (non-protein coding) | ||
+ | |- | ||
+ | |''ESRG'' | ||
+ | |[[ENST00000583516.1]] | ||
+ | |HESRG | ||
+ | |embryonic stem cell related (non-protein coding) | ||
+ | |- | ||
+ | |''Evf2'' | ||
+ | |[[lnc-DLX5-3:1]] | ||
+ | |Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | ||
+ | | | ||
+ | |- | ||
+ | |''FENDRR'' | ||
+ | |[[FENDRR]] | ||
+ | |FOXF1 adjacent non-coding developmental regulatory RNA | ||
+ | |lincFOXF1, onco-lncRNA-21 | ||
+ | |- | ||
+ | |''FIRRE'' | ||
+ | |[[ENST00000427391.1]] | ||
+ | |firre intergenic repeating RNA element | ||
+ | |LINC01200 | ||
+ | |- | ||
+ | |''FOXCUT'' | ||
+ | |[[Lnc-FOXC1-1:1]],[[NONHSAT106529]] | ||
+ | |TCONS_00011636 | ||
+ | |FOXC1 upstream transcript (non-protein coding) | ||
+ | |- | ||
+ | |''FTX'' | ||
+ | |[[ENST00000602812.1]] | ||
+ | |LINC00182,FLJ33139 | ||
+ | |FTX transcript, XIST regulator (non-protein coding) | ||
+ | |- | ||
+ | |''GHET1'' | ||
+ | |[[GHET1]] | ||
+ | |lncRNA-GHET1 | ||
+ | |gastric carcinoma proliferation enhancing transcript 1 | ||
+ | |- | ||
+ | |''GHRLOS'' | ||
+ | |[[NONHSAT087920]] | ||
+ | |NCRNA00068,GHRL-AS1 | ||
+ | |ghrelin opposite strand/antisense RNA | ||
+ | |- | ||
+ | |''GPR1-AS'' | ||
+ | |[[NONHSAT076558]] | ||
+ | |GPR1AS | ||
+ | |GPR1 antisense RNA | ||
+ | |- | ||
+ | |''HAGLR'' | ||
+ | |[[ENST00000416928.2]],[[NONHSAT075638]] | ||
+ | |Mdgt | ||
+ | |HOXD antisense growth-associated long non-coding RNA | ||
+ | |- | ||
+ | |''HEIH'' | ||
+ | |[[HEIH]] | ||
+ | |LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2 | ||
+ | |hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA | ||
+ | |- | ||
+ | |''JADRR'' | ||
+ | |[[JADRR]] | ||
+ | |lncRNA-JADE | ||
+ | |JADE1 adjacent regulatory RNA | ||
+ | |- | ||
+ | |''KANTR'' | ||
+ | |[[ENST00000604849.1]] | ||
+ | |KDM5C adjacent non-coding transcript | ||
+ | |Spasm | ||
+ | |- | ||
+ | |''LINC-PINT'' | ||
+ | |[[NONHSAT123382]] | ||
+ | |FLJ43663, PINT, LincRNA-Pint | ||
+ | |long intergenic non-protein coding RNA, p53 induced transcript | ||
+ | |- | ||
+ | |''LINC00163'' | ||
+ | |[[LINC00163]] | ||
+ | |NLC1-A, NLC1A | ||
+ | |long intergenic non-protein coding RNA 163 | ||
+ | |- | ||
+ | |''LINC00312'' | ||
+ | |[[NONHSAT087716]] | ||
+ | |NAG7, NAG-7, ERR10, LMCD1DN, ERR-10 | ||
+ | |long intergenic non-protein coding RNA 312 | ||
+ | |- | ||
+ | |''LINC00850'' | ||
+ | |[[LINC00850]] | ||
+ | |KUCG1 | ||
+ | |long intergenic non-protein coding RNA 850 | ||
+ | |- | ||
+ | |''LINC01191'' | ||
+ | |[[ENST00000412690.1]] | ||
+ | |VIN, lnc-ACTR3 | ||
+ | |long intergenic non-protein coding RNA 1191 | ||
+ | |- | ||
+ | |''LSINCT5'' | ||
+ | |[[LSINCT5]] | ||
+ | |N/A | ||
+ | |long stress-induced non-coding transcript 5 | ||
+ | |- | ||
+ | |''LUCAT1'' | ||
+ | |[[ENST00000511918.1]] | ||
+ | |SCAL1 | ||
+ | |lung cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''MIR22HG'' | ||
+ | |[[ENST00000574306.1]] | ||
+ | |MGC14376, DKFZp686O06159, LOC554202 | ||
+ | |MIR22 host gene | ||
+ | |- | ||
+ | |''MIR31HG'' | ||
+ | |[[NONHSAT130385]] | ||
+ | |LOC554202 | ||
+ | |MIR31 host gene | ||
+ | |- | ||
+ | |''MIR99AHG'' | ||
+ | |[[ENST00000602580.1]] | ||
+ | |MONC | ||
+ | |mir-99a-let-7c cluster host gene | ||
+ | |- | ||
+ | |''MIR100HG'' | ||
+ | |[[ENST00000531381.1]] | ||
+ | |AGD1, lncRNA-N2 | ||
+ | |mir-100-let-7a-2 cluster host gene | ||
+ | |- | ||
+ | |''MIR155HG'' | ||
+ | |[[NONHSAT081499]] | ||
+ | |BIC, NCRNA00172 | ||
+ | |MIR155 host gene | ||
+ | |- | ||
+ | |''MIR222HG'' | ||
+ | |[[ENST00000602507.1]] | ||
+ | |Lnc-Ang362 | ||
+ | |MIR222 host gene | ||
+ | |- | ||
+ | |''MIR503HG'' | ||
+ | |[[ENST00000414769.1]] | ||
+ | |MGC16121, H19X | ||
+ | |MIR503 host gene | ||
+ | |- | ||
+ | |''MYCNUT'' | ||
+ | |[[ENST00000433810.1]] | ||
+ | |lncUSMycN | ||
+ | |MYCN upstream transcript (non-protein coding) | ||
+ | |- | ||
+ | |''NAMA'' | ||
+ | |[[ENST00000604258.1]] | ||
+ | |N/A | ||
+ | |non-protein coding RNA, associated with MAP kinase pathway and growth arrest | ||
+ | |- | ||
+ | |''NRIR'' | ||
+ | |[[ENST00000414795.1]] | ||
+ | |lncRNA-CMPK2 | ||
+ | |negative regulator of interferon response (non-protein coding) | ||
+ | |- | ||
+ | |''OIP5-AS1'' | ||
+ | |[[ENST00000500949.2]] | ||
+ | |cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | ||
+ | |OIP5 antisense RNA 1 | ||
+ | |- | ||
+ | |''OVAAL'' | ||
+ | |[[ENST00000442621.1]] | ||
+ | |LINC01131,OVAL | ||
+ | |ovarian adenocarcinoma amplified long non-coding RNA | ||
+ | |- | ||
+ | |''PACERR'' | ||
+ | |[[ENST00000608917.1]] | ||
+ | |PACER, PTGS2-AS1 | ||
+ | |PTGS2 antisense NFKB1 complex-mediated expression regulator RNA | ||
+ | |- | ||
+ | |''PART1'' | ||
+ | |[[ENST00000506884.1]] | ||
+ | |DKFZP586D0823, NCRNA00206 | ||
+ | |prostate androgen-regulated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''PAUPAR'' | ||
+ | |[[NONHSAT018635]] | ||
+ | |N/A | ||
+ | |PAX6 upstream antisense RNA | ||
+ | |- | ||
+ | |''PCA3'' | ||
+ | |[[ENST00000412654.1]] | ||
+ | |DD3, NCRNA00019, PCAT3 | ||
+ | |prostate cancer associated 3 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT1'' | ||
+ | |[[ENST00000561978.1]] | ||
+ | |PCAT-1, PCA1 | ||
+ | |prostate cancer associated transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT4'' | ||
+ | |[[ENST00000504263.1]] | ||
+ | |GDEP, PCAN1, PCA4 | ||
+ | |prostate cancer associated transcript 4 (non-protein coding) | ||
+ | |- | ||
+ | |''PCAT7'' | ||
+ | |[[ENST00000452148.2]] | ||
+ | |PCAN-R2 | ||
+ | |prostate cancer associated transcript 7 (non-protein coding) | ||
+ | |- | ||
+ | |''PRNCR1'' | ||
+ | |[[NONHSAT129019]] | ||
+ | |N/A | ||
+ | |prostate cancer associated non-coding RNA 1 | ||
+ | |- | ||
+ | |''PTCSC2'' | ||
+ | |[[ENST00000430058.1]] | ||
+ | |N/A | ||
+ | |papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) | ||
+ | |- | ||
+ | |''PTCSC3'' | ||
+ | |[[ENST00000556013.2]] | ||
+ | |N/A | ||
+ | |papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) | ||
+ | |- | ||
+ | |''PVT1'' | ||
+ | |[[ENST00000513868.2]] | ||
+ | |NCRNA00079, LINC00079, onco-lncRNA-100 | ||
+ | |Pvt1 oncogene (non-protein coding) | ||
+ | |- | ||
+ | |''PWRN1'' | ||
+ | |[[NONHSAT040920]] | ||
+ | |NCRNA00198 | ||
+ | |Prader-Willi region non-protein coding RNA 1 | ||
+ | |- | ||
+ | |''PWRN2'' | ||
+ | |[[NONHSAT040875]] | ||
+ | |NCRNA00199 | ||
+ | |Prader-Willi region non-protein coding RNA 2 | ||
+ | |- | ||
+ | |''RASSF1-AS1'' | ||
+ | |[[RASSF1-AS1]] | ||
+ | |RASSF1 antisense RNA 1 | ||
+ | |ANRASSF1 | ||
+ | |- | ||
+ | |''SCAANT1'' | ||
+ | |[[SCAANT1]] | ||
+ | |SCA7/ATXN7 antisense RNA 1 | ||
+ | |ATXN7-AS1 | ||
+ | |- | ||
+ | |''SCHLAP1'' | ||
+ | |[[NONHSAT075852]] | ||
+ | |SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | ||
+ | |SChLAP1,PCAT11 | ||
+ | |- | ||
+ | |''SENCR'' | ||
+ | |[[ENST00000526269.2]] | ||
+ | |smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | ||
+ | |N/A | ||
+ | |- | ||
+ | |''TARID'' | ||
+ | |[[ENST00000607033.1]] | ||
+ | |N/A | ||
+ | |TCF21 antisense RNA inducing promoter demethylation | ||
+ | |- | ||
+ | |''WFDC21P'' | ||
+ | |[[Lnc-HEATR6-1:4]] | ||
+ | |WAP four-disulfide core domain 21, pseudogene | ||
+ | |LOC645638, lnc-DC, LNCDC | ||
+ | |- | ||
+ | |''GAS5'' | ||
+ | |[[NONHSAT007663]] | ||
+ | |SNHG2, ENSG00000234741 | ||
+ | | | ||
+ | |- | ||
+ | |''MIAT'' | ||
+ | |[[lnc-CRYBA4-2:1]] | ||
+ | |FLJ25967, gomafu, LINC00066, lncRNA-MIAT, "long intergenic non-protein coding RNA 66", NCRNA00066, "non-protein coding RNA 66", Rncr2 | ||
+ | |myocardial infarction associated transcript (non-protein coding) | ||
+ | |- | ||
+ | |''H19'' | ||
+ | |[[NONHSAT017465]] | ||
+ | |Q96MK8,ENSG00000130600 | ||
+ | |H19, imprinted maternally expressed transcript (non-protein coding) | ||
+ | |- | ||
+ | |''HAR1A'' | ||
+ | |[[lnc-BIRC7-2:1]] | ||
+ | |HAR1F, ENSG00000238820 | ||
+ | |highly accelerated region 1A | ||
+ | |- | ||
+ | |''HAR1B'' | ||
+ | |[[ENST00000447910.2]] | ||
+ | |HAR1R, ENSG00000231133 | ||
+ | |highly accelerated region 1B | ||
+ | |- | ||
+ | |''HOTAIR'' | ||
+ | |[[NONHSAT028508]] | ||
+ | |Gm16258, Hox antisense intergenic RNA, ENSG00000228630 | ||
+ | |Hox antisense intergenic RNA | ||
+ | |- | ||
+ | |''HOTAIRM1'' | ||
+ | |[[lnc-EVX1-12:1]] | ||
+ | |HIT06113, HIT92376, linc1548, ENSG00000233429 | ||
+ | |HOXA transcript antisense RNA, myeloid-specific 1 | ||
+ | |- | ||
+ | |''HOTTIP'' | ||
+ | |[[NONHSAT119717]] | ||
+ | |HOXA13as, HIT18844, NCRNA00213, ENSG00000243766 | ||
+ | |HOXA transcript at the distal tip | ||
+ | |- | ||
+ | |''HOXA11-AS'' | ||
+ | |[[NONHSAT119704]] | ||
+ | |"HOXA cluster antisense RNA 5 (non-protein coding)", HOXA-AS5, "HOXA11 antisense RNA 1 (non-protein coding)", HOXA11-AS1, HOXA11S, NCRNA00076, "non-protein coding RNA 76", ENSG00000240990 | ||
+ | |HOXA11 antisense RNA | ||
+ | |- | ||
+ | |''HOXA-AS2'' | ||
+ | |[[NONHSAT119676]] | ||
+ | |HOXA3as, ENSG00000253552 | ||
+ | |HOXA cluster antisense RNA 2 | ||
+ | |- | ||
+ | |''HOXA-AS3'' | ||
+ | |[[lnc-EVX1-9:1]] | ||
+ | |HOXA6as | ||
+ | |HOXA cluster antisense RNA 3 | ||
+ | |- | ||
+ | |''HULC'' | ||
+ | |[[NONHSAT107640]] | ||
+ | |ENSG00000251164 | ||
+ | |hepatocellular carcinoma up-regulated long non-coding RNA | ||
+ | |- | ||
+ | |''IPW'' | ||
+ | |[[NONHSAT041063]] | ||
+ | |NCRNA00002 | ||
+ | |imprinted in Prader-Willi syndrome | ||
+ | |- | ||
+ | |''JPX'' | ||
+ | |[[lnc-ZCCHC13-1:1]] | ||
+ | |DCBALD06, ENOX, "expressed neighbor of XIST", "just proximal to XIST", LINC00183 | ||
+ | |JPX transcript, XIST activator (non-protein coding) | ||
+ | |- | ||
+ | |''KCNQ1OT1'' | ||
+ | |[[NONHSAT017524]] | ||
+ | |"KCNQ1 antisense RNA 2 (non-protein coding)", "KCNQ1 overlapping transcript 1 (non-protein coding)", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, "non-protein coding RNA 12" | ||
+ | |KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''KRASP1'' | ||
+ | |[[NONHSAT113225]] | ||
+ | |ENSG00000220635 | ||
+ | |KRAS Pseudogene 1 | ||
+ | |- | ||
+ | |''FALEC'' | ||
+ | |[[ENST00000416894.1]] | ||
+ | |LINC00568, "long intergenic non-protein coding RNA 568", ENSG00000228126.1 | ||
+ | |focally amplified long non-coding RNA in epithelial cancer | ||
+ | |- | ||
+ | |''lincRNA-ROR'' | ||
+ | |[[NONHSAT059436]] | ||
+ | |ROR, lincRNA-ST8SIA3, ENSG00000258609 | ||
+ | |long intergenic non-protein coding RNA, regulator of reprogramming | ||
+ | |- | ||
+ | |''LOC100887755'' | ||
+ | |[[lnc-SNAI1-1:1]] | ||
+ | |Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1 | ||
+ | |translation regulatory long non-coding RNA 1 | ||
+ | |- | ||
+ | |''TUSC7'' | ||
+ | |[[NONHSAT091315]] | ||
+ | |LINC00902, LOC285194, ENSG00000243197 | ||
+ | |tumor suppressor candidate 7 (non-protein coding) | ||
+ | |- | ||
+ | |''RBM5-AS1'' | ||
+ | |[[NONHSAT089783]] | ||
+ | |"LUCA-15-specific transcript", LUST, ENSG00000003756 | ||
+ | |RBM5 antisense RNA 1 | ||
+ | |- | ||
+ | |''MALAT1'' | ||
+ | |[[ENST00000534336.1]] | ||
+ | |HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | ||
+ | |metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''mascRNA'' | ||
+ | |[[lnc-SCYL1-1:5]] | ||
+ | |Malat1 | ||
+ | |mascRNA (MALAT1-associated small cytoplasmic RNA) | ||
+ | |- | ||
+ | |''MEG3'' | ||
+ | |[[NONHSAT039745]] | ||
+ | |Gtl2, ENSG00000214548 | ||
+ | |maternally expressed 3 (non-protein coding) | ||
+ | |- | ||
+ | |''ncR-PAR'' | ||
+ | |[[NONHSAT102247]] | ||
+ | |NCRUPAR, ENSG00000225407 | ||
+ | |non-protein coding RNA, upstream of F2R/PAR1 | ||
+ | |- | ||
+ | |''NDM29'' | ||
+ | |[[lnc-C11orf16-1:1]] | ||
+ | |29A | ||
+ | |neuroblastoma differentiation marker 29 ([http://www.ncbi.nlm.nih.gov/pubmed/20581224 Castelnuovo (2010)], [http://www.ncbi.nlm.nih.gov/pubmed/17274687 Pagano (2007)]). | ||
+ | |- | ||
+ | |''GNAS-AS1'' | ||
+ | |[[lnc-CTSZ-5:1]] | ||
+ | |"GNAS antisense", GNAS1AS, NCRNA00075, NESP-AS, NESPAS, "non-protein coding RNA 75", SANG, ENSG00000235590 | ||
+ | |neuroendocrine secretory protein (Nesp) antisense. | ||
+ | |- | ||
+ | |''NRON'' | ||
+ | |[[NONHSAT134764]] | ||
+ | |ENSG00000253079 | ||
+ | |non-protein coding RNA, repressor of NFAT | ||
+ | |- | ||
+ | |''NTT'' | ||
+ | |[[NONHSAT115106]] | ||
+ | | | ||
+ | |noncoding transcript in T cells. | ||
+ | |- | ||
+ | |''OTX2-AS1'' | ||
+ | |[[lnc-C14orf101-5:1]] | ||
+ | |OTX2OS1, ENSG00000248550 | ||
+ | |OTX2 antisense RNA 1 (head to head) | ||
+ | |- | ||
+ | |''PANDAR'' | ||
+ | |[[lnc-CDKN1A-1:1]] | ||
+ | |P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR | ||
+ | |promoter of CDKN1A antisense DNA damage activated RNA | ||
+ | |- | ||
+ | |''PCGEM1'' | ||
+ | |[[NONHSAT076153]] | ||
+ | |ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA | ||
+ | |Prostate-specific transcript 1 | ||
+ | |- | ||
+ | |''LINC00853'' | ||
+ | |[[ENST00000429328.2]] | ||
+ | |"PDZK1IP1 antisense RNA 1 (non-protein coding)", "PDZK1IP1 antisense RNA 1 (tail to tail)", PDZK1IP1-AS1 ,ENSG00000224805 | ||
+ | |long intergenic non-protein coding RNA 853 | ||
+ | |- | ||
+ | |''PRINS'' | ||
+ | |[[NONHSAT011777]] | ||
+ | |ENSG00000238115 | ||
+ | |Psoriasis susceptibility-related RNA Gene Induced by Stress | ||
+ | |- | ||
+ | |''PTENP1'' | ||
+ | |[[NONHSAT130775]] | ||
+ | |PTENpg1, PTEN2, ENSG00000237984 | ||
+ | |PTEN Pseudogene 1 | ||
+ | |- | ||
+ | |''MEG8'' | ||
+ | |[[ENST00000553584.1]] | ||
+ | |Bsr, "Imprinted RNA near Meg3/Gtl2", Irm, LINC00024, "long intergenic non-protein coding RNA 24", NCRNA00024, "non-protein coding RNA 24", Rian, "RNA Imprinted and Accumulated in Nucleus", ENSG00000258399 | ||
+ | |Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 | ||
+ | |- | ||
+ | |''LINC00599'' | ||
+ | |[[lnc-TNKS-1:1]] | ||
+ | |"retinal non-coding RNA 3", Rncr3, ENSG00000253230 | ||
+ | |Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599 | ||
+ | |- | ||
+ | |''FAS-AS'' | ||
+ | |[[NONHSAT015489]] | ||
+ | |SAF, ENSG00000026103 | ||
+ | |FAS antisense RNA 1 | ||
+ | |- | ||
+ | |''ATXN8OS'' | ||
+ | |[[NONHSAT034251]] | ||
+ | |NCRNA00003, "non-protein coding RNA 3", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223 | ||
+ | |Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand | ||
+ | |- | ||
+ | |''SNHG1'' | ||
+ | |[[NONHSAT021826]] | ||
+ | |UHG, ENSG00000255717 | ||
+ | |SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | ||
+ | |- | ||
+ | |''SNHG3'' | ||
+ | |[[lnc-OR10H5-1:1]] | ||
+ | |U17HG, linc1343, ENSG00000242125 | ||
+ | |Small nucleolar RNA host gene 3 | ||
+ | |- | ||
+ | |''SNHG4'' | ||
+ | |[[NONHSAT104072]] | ||
+ | |U19H, ENSG00000200959 | ||
+ | |Small nucleolar RNA host gene 4 | ||
+ | |- | ||
+ | |''SNHG5'' | ||
+ | |[[NONHSAT054526]] | ||
+ | |U50HG, ENSG00000203875 | ||
+ | |Small nucleolar RNA host gene 5 | ||
+ | |- | ||
+ | |''SNHG6'' | ||
+ | |[[lnc-TCF24-2:3]] | ||
+ | |U87HG, ENSG00000245910 | ||
+ | |Small nucleolar RNA host gene 6 | ||
+ | |- | ||
+ | |''SPRY4-IT1'' | ||
+ | |[[lnc-NDFIP1-3:1]] | ||
+ | |AK024556, ENSG00000274721 | ||
+ | |SPRY4 intronic transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''SRA'' | ||
+ | |[[lnc-SRA1-1:1]] | ||
+ | |SRA1, ENSG00000213523 | ||
+ | |Steroid receptor RNA Activator | ||
+ | |- | ||
+ | |''TEA-ncRNAs'' | ||
+ | |[[NONHSAT035776]] | ||
+ | |ENSG00000251002 | ||
+ | |T early alpha | ||
+ | |- | ||
+ | |''IFNG-AS1'' | ||
+ | |[[ENST00000538665.1]] | ||
+ | |LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733 | ||
+ | |IFNG antisense RNA 1 | ||
+ | |- | ||
+ | |''TncRNA'' | ||
+ | |[[NONHSAT022116]] | ||
+ | |TSU | ||
+ | |TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | ||
+ | |- | ||
+ | |''TUG1'' | ||
+ | |[[NONHSAT084827]] | ||
+ | |ENSG00000253352 | ||
+ | |taurine up-regulated gene 1 [http://www.ncbi.nlm.nih.gov/pubmed/15797018 (Young (2005))]. | ||
+ | |- | ||
+ | |''UCA1'' | ||
+ | |[[lnc-OR10H5-1:1]] | ||
+ | |UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | ||
+ | |urothelial cancer associated 1 (non-protein coding) | ||
+ | |- | ||
+ | |''KCNIP4-IT1'' | ||
+ | |[[NONHSAT095745]] | ||
+ | |"non coding transcript UM9(5)", UM9-5 | ||
+ | |KCNIP4 intronic transcript 1 (non-protein coding) | ||
+ | |- | ||
+ | |''WT1-AS'' | ||
+ | |[[lnc-EIF3M-1:1]] | ||
+ | |WIT1, ENSG00000183242 | ||
+ | |WT1 (Wilms' tumor 1) antisense transcript | ||
+ | |- | ||
+ | |''XIST'' | ||
+ | |[[NONHSAT137541]] | ||
+ | |ENSG00000229807 | ||
+ | |X inactive-specific transcript | ||
+ | |- | ||
+ | |''ZEB2-AS1'' | ||
+ | |[[NONHSAT074775]] | ||
+ | |Zeb2NAT, ENSG00000238057 | ||
+ | |Zeb2 natural antisense transcript | ||
+ | |- | ||
+ | |''ZFAS1'' | ||
+ | |[[NONHSAT080206]] | ||
+ | |Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410 | ||
+ | |ZNFX1 antisense RNA 1 | ||
+ | |- | ||
+ | |''Zfhx2as'' | ||
+ | |[[ENST00000554403.1]] | ||
+ | |Zfh-5AS, ENSG00000157306 | ||
+ | |zinc finger homeobox 2, antisense | ||
+ | |- | ||
+ | |''TMEM161B-AS1'' | ||
+ | |[[lnc-RASA1-3:23]],[[lnc-RASA1-3:25]] | ||
+ | |AK082072,linc-POLR3G-8, ENSG00000247828 | ||
+ | |TMEM161B antisense RNA 1 | ||
+ | |- | ||
+ | |''Alpha 250''/ ''Alpha 280'' | ||
+ | |[[NONHSAT104559]],[[lnc-NDST1-1:2]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''CDKN2B-AS1'' | ||
+ | |[[NONHSAT130421]],[[lnc-C9orf53-2:1]] | ||
+ | |ANRIL, p15AS, ENSG00000240498 | ||
+ | |CDKN2B antisense RNA 1 | ||
+ | |- | ||
+ | |''BACE1-AS'' | ||
+ | |[[NONHSAT024403]],[[lnc-RNF214-1:2]] | ||
+ | |BACE1AS,NCRNA00177; FJ573250 | ||
+ | |BACE1 antisense RNA | ||
+ | |- | ||
+ | |''Beta-globin transcripts'' | ||
+ | |[[NONHSAT017676]],[[NONHSAT017675]],[[NONHSAT017674]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''LINC00581'' | ||
+ | |[[lnc-PRL-6:2]],[[lnc-PRL-6:1]] | ||
+ | |BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678 | ||
+ | |long intergenic non-protein coding RNA 581 | ||
+ | |- | ||
+ | |''CAR Intergenic 10'' | ||
+ | |[[NONHSAT016928]],[[lnc-FANK1-3:1]] | ||
+ | |Intergenic10, CR611911, AK055628 | ||
+ | |Chromatin Associated RNA 10 | ||
+ | |- | ||
+ | |''DIO3OS'' | ||
+ | |[[NONHSAT040032]],[[NONHSAT040039]] | ||
+ | |DIO3-AS1, NCRNA00041, "non-protein coding RNA 41", ENSG00000258498 | ||
+ | |DIO3 opposite strand/antisense RNA (head to head) | ||
+ | |- | ||
+ | |''PCAT6'' | ||
+ | |[[ENST00000425295.1]],[[ENST00000553157.1]],[[ENST00000417262.1]] | ||
+ | |Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''LINC00570'' | ||
+ | |[[ENST00000437795.1]],[[ENST00000432665.1]],[[ENST00000453100.1]],[[ENST00000417473.2]] | ||
+ | |KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, "prostate cancer-associated noncoding RNA 1",ENSG00000224177, | ||
+ | |prostate cancer associated transcript 6 (non-protein coding) | ||
+ | |- | ||
+ | |''NEAT1'' | ||
+ | |[[ENST00000501122.2]],[[NONHSAT022111]] | ||
+ | |MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532 | ||
+ | |Nuclear enriched abundant transcript 1. | ||
+ | |- | ||
+ | |''ST7OT'' | ||
+ | |[[NONHSAT122926]],[[NONHSAT122918]],[[NONHSAT122914]],[[NONHSAT122932]] | ||
+ | |ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188 | ||
+ | |N/A | ||
+ | |- | ||
+ | |''snaR'' | ||
+ | |[[lnc-BSPH1-1:1]],[[lnc-BSPH1-2:1]] | ||
+ | |small NF90-associated RNAs | ||
+ | |small NF90-associated RNAs | ||
+ | |- | ||
+ | |''Y RNAs'' | ||
+ | |[[lnc-PDIA4-1:1]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''PR antisense transcripts'' | ||
+ | |[[NONHSAT023851]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |''FAM3D-AS1'' | ||
+ | |[[FAM3D-AS1]] | ||
+ | |lnc-KCTD6-3 | ||
+ | |FAM3D antisense RNA 1 | ||
+ | |- | ||
+ | |''SHANK2-AS3'' | ||
+ | |[[SHANK2-AS3]] | ||
+ | |N/A | ||
+ | |SHANK2 antisense RNA 3 | ||
+ | |- | ||
+ | |''AATBC'' | ||
+ | |[[AATBC]] | ||
+ | |N/A | ||
+ | |apoptosis associated transcript in bladder cancer | ||
+ | |- | ||
+ | |''ABHD11-AS1'' | ||
+ | |[[ABHD11-AS1]] | ||
+ | |NCRNA00035 | ||
+ | |ABHD11 antisense RNA 1 (tail to tail) | ||
+ | |- | ||
+ | |''ABHD15-AS1'' | ||
+ | |[[ABHD15-AS1]] | ||
+ | |linc-TP53I13, lnc-TP53I13 | ||
+ | |ABHD15 antisense RNA 1 | ||
+ | |- | ||
+ | |''ACTA2-AS1'' | ||
+ | |[[ACTA2-AS1]] | ||
+ | |uc001kfo.1, ZXF1 | ||
+ | |ACTA2 antisense RNA 1 | ||
+ | |- | ||
+ | |''ADAMTS9-AS2'' | ||
+ | |[[ADAMTS9-AS2]] | ||
+ | |N/A | ||
+ | |ADAMTS9 antisense RNA 2 | ||
+ | |- | ||
+ | |''ADORA2A-AS1'' | ||
+ | |[[ADORA2A-AS1]] | ||
+ | |FLJ34651 | ||
+ | |ADORA2A antisense RNA 1 | ||
+ | |- | ||
+ | |''AFAP1-AS1'' | ||
+ | |[[AFAP1-AS1]] | ||
+ | |MGC10981 | ||
+ | |AFAP1 antisense RNA 1 | ||
+ | |- | ||
+ | |''AGAP2-AS1'' | ||
+ | |[[AGAP2-AS1]] | ||
+ | |LOC100130776, PUNISHER | ||
+ | |AGAP2 antisense RNA 1 | ||
+ | |- | ||
+ | |''Alpha 250''/''Alpha 280'' | ||
+ | |[[NONHSAT104559]],[[lnc-NDST1-1:2]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |''ANP32A-IT1'' | ||
+ | |[[ANP32A-IT1]] | ||
+ | |FLJ11722, HsT18971 | ||
+ | |ANP32A intronic transcript 1 | ||
|- | |- | ||
|''ARRDC1-AS1'' | |''ARRDC1-AS1'' | ||
Line 120: | Line 859: | ||
|MGC16179 | |MGC16179 | ||
|ATP1A1 antisense RNA 1 | |ATP1A1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''B3GALT5-AS1'' | |''B3GALT5-AS1'' | ||
Line 140: | Line 874: | ||
|MGC39526 | |MGC39526 | ||
|BAALC antisense RNA 2 | |BAALC antisense RNA 2 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''BCAR4'' | |''BCAR4'' | ||
Line 155: | Line 879: | ||
|N/A | |N/A | ||
|breast cancer anti-estrogen resistance 4 (non-protein coding) | |breast cancer anti-estrogen resistance 4 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''BFSP2-AS1'' | |''BFSP2-AS1'' | ||
Line 200: | Line 909: | ||
|N/A | |N/A | ||
|BST2 interferon stimulated positive regulator (non-protein coding) | |BST2 interferon stimulated positive regulator (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''BOK-AS1'' | |''BOK-AS1'' | ||
Line 210: | Line 914: | ||
|NCRNA00151, NAToB | |NCRNA00151, NAToB | ||
|BOK antisense RNA 1 | |BOK antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''BRWD1-AS2'' | |''BRWD1-AS2'' | ||
Line 250: | Line 949: | ||
|N/A | |N/A | ||
|CACNA1G antisense RNA 1 | |CACNA1G antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CAPN10-AS1'' | |''CAPN10-AS1'' | ||
Line 260: | Line 954: | ||
|locus959 | |locus959 | ||
|CAPN10 antisense RNA 1 (head to head) | |CAPN10 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CARD8-AS1'' | |''CARD8-AS1'' | ||
Line 305: | Line 994: | ||
|TCONSN/A00024290, LincRNA-ENST00000515084 | |TCONSN/A00024290, LincRNA-ENST00000515084 | ||
|cancer susceptibility candidate 22 (non-protein coding) | |cancer susceptibility candidate 22 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CASC9'' | |''CASC9'' | ||
Line 320: | Line 1,004: | ||
|PlncRNA-1 | |PlncRNA-1 | ||
|CBR3 antisense RNA 1 | |CBR3 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CCDC18-AS1'' | |''CCDC18-AS1'' | ||
Line 350: | Line 1,024: | ||
|p21NAT | |p21NAT | ||
|CDKN1A antisense RNA 1 | |CDKN1A antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CDR1-AS'' | |''CDR1-AS'' | ||
Line 400: | Line 1,069: | ||
|MGC39338 | |MGC39338 | ||
|CIRBP antisense RNA 1 | |CIRBP antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CLRN1-AS1'' | |''CLRN1-AS1'' | ||
Line 420: | Line 1,084: | ||
|PRO0132, CPS1-IT | |PRO0132, CPS1-IT | ||
|CPS1 intronic transcript 1 | |CPS1 intronic transcript 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CSNK1G2-AS1'' | |''CSNK1G2-AS1'' | ||
Line 450: | Line 1,109: | ||
|MGC34824 | |MGC34824 | ||
|CYP1B1 antisense RNA 1 | |CYP1B1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''CYP51A1-AS1'' | |''CYP51A1-AS1'' | ||
Line 460: | Line 1,114: | ||
|ENST00000453068, LRRD1-AS1 | |ENST00000453068, LRRD1-AS1 | ||
|CYP51A1 antisense RNA 1 | |CYP51A1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DACOR1'' | |''DACOR1'' | ||
Line 470: | Line 1,119: | ||
|TCONSN/A00023265 | |TCONSN/A00023265 | ||
|DNMT1-associated colon cancer repressed lncRNA 1 | |DNMT1-associated colon cancer repressed lncRNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DANT1'' | |''DANT1'' | ||
Line 500: | Line 1,139: | ||
|N/A | |N/A | ||
|DAPK1 intronic transcript 1 | |DAPK1 intronic transcript 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DBH-AS1'' | |''DBH-AS1'' | ||
Line 535: | Line 1,169: | ||
|DGS-A, POM121L5P | |DGS-A, POM121L5P | ||
|DiGeorge syndrome critical region gene 9 (non-protein coding) | |DiGeorge syndrome critical region gene 9 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DIAPH2-AS1'' | |''DIAPH2-AS1'' | ||
Line 550: | Line 1,174: | ||
|N/A | |N/A | ||
|DIAPH2 antisense RNA 1 | |DIAPH2 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DISC1FP1'' | |''DISC1FP1'' | ||
Line 560: | Line 1,179: | ||
|N/A | |N/A | ||
|DISC1 fusion partner 1 (non-protein coding) | |DISC1 fusion partner 1 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''DLG2-AS1'' | |''DLG2-AS1'' | ||
Line 620: | Line 1,224: | ||
|N/A | |N/A | ||
|EGFR antisense RNA 1 | |EGFR antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ELFN1-AS1'' | |''ELFN1-AS1'' | ||
Line 630: | Line 1,229: | ||
|N/A | |N/A | ||
|ELFN1 antisense RNA 1 | |ELFN1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ENTPD3-AS1'' | |''ENTPD3-AS1'' | ||
Line 655: | Line 1,249: | ||
|Po42 | |Po42 | ||
|ERC2 intronic transcript 1 | |ERC2 intronic transcript 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ERICH1-AS1'' | |''ERICH1-AS1'' | ||
Line 665: | Line 1,254: | ||
|N/A | |N/A | ||
|ERICH1 antisense RNA 1 | |ERICH1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''EWSAT1'' | |''EWSAT1'' | ||
Line 695: | Line 1,274: | ||
|N/A | |N/A | ||
|F11 antisense RNA 1 | |F11 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''FAM138A'' | |''FAM138A'' | ||
Line 795: | Line 1,369: | ||
|N/A | |N/A | ||
|family with sequence similarity 87 member A | |family with sequence similarity 87 member A | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''FAS-AS1'' | |''FAS-AS1'' | ||
Line 805: | Line 1,374: | ||
|SAF | |SAF | ||
|FAS antisense RNA 1 | |FAS antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''FGF10-AS1'' | |''FGF10-AS1'' | ||
Line 815: | Line 1,379: | ||
|RP11-473L15.2 | |RP11-473L15.2 | ||
|FGF10 antisense RNA 1 | |FGF10 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''FLG-AS1'' | |''FLG-AS1'' | ||
Line 840: | Line 1,399: | ||
|ODRUL | |ODRUL | ||
|FOXC2 antisense RNA 1 | |FOXC2 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''FOXG1-AS1'' | |''FOXG1-AS1'' | ||
Line 855: | Line 1,409: | ||
|LncRNA-AP001631.9 | |LncRNA-AP001631.9 | ||
|FOXM1-regulated, gastric cancer associated | |FOXM1-regulated, gastric cancer associated | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''GABPB1-AS1'' | |''GABPB1-AS1'' | ||
Line 890: | Line 1,439: | ||
|LncRNA-Hh | |LncRNA-Hh | ||
|GAS1 adjacent regulatory RNA | |GAS1 adjacent regulatory RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''GAS6-AS1'' | |''GAS6-AS1'' | ||
Line 920: | Line 1,464: | ||
|GDNFOS | |GDNFOS | ||
|GDNF antisense RNA 1 (head to head) | |GDNF antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''GLIDR'' | |''GLIDR'' | ||
Line 940: | Line 1,474: | ||
|MGC16153 | |MGC16153 | ||
|GLIS3 antisense RNA 1 | |GLIS3 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''GNG12-AS1'' | |''GNG12-AS1'' | ||
Line 950: | Line 1,479: | ||
|N/A | |N/A | ||
|GNG12 antisense RNA 1 | |GNG12 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''GTSCR1'' | |''GTSCR1'' | ||
Line 960: | Line 1,484: | ||
|N/A | |N/A | ||
|Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) | |Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''H1FX-AS1'' | |''H1FX-AS1'' | ||
Line 970: | Line 1,489: | ||
|FLJ34151 | |FLJ34151 | ||
|H1FX antisense RNA 1 | |H1FX antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''HAND2-AS1'' | |''HAND2-AS1'' | ||
Line 980: | Line 1,494: | ||
|DEIN, NBLA00301, FLJ11539 | |DEIN, NBLA00301, FLJ11539 | ||
|HAND2 antisense RNA 1 (head to head) | |HAND2 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''HAS2-AS1'' | |''HAS2-AS1'' | ||
Line 1,025: | Line 1,529: | ||
|D6S2650E, P5-1 | |D6S2650E, P5-1 | ||
|HLA complex P5 (non-protein coding) | |HLA complex P5 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''HELLPAR'' | |''HELLPAR'' | ||
Line 1,065: | Line 1,564: | ||
|MTMR3-AS1, NONHSAG033653 | |MTMR3-AS1, NONHSAG033653 | ||
|HORMAD2 antisense RNA 1 | |HORMAD2 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''HPVC1'' | |''HPVC1'' | ||
Line 1,105: | Line 1,574: | ||
|HTTAS | |HTTAS | ||
|HTT antisense RNA (head to head) | |HTT antisense RNA (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''HYMAI'' | |''HYMAI'' | ||
Line 1,120: | Line 1,584: | ||
|HT009, Em:AC022536.4 | |HT009, Em:AC022536.4 | ||
|IDI2 antisense RNA 1 | |IDI2 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''IGF2-AS'' | |''IGF2-AS'' | ||
Line 1,145: | Line 1,604: | ||
|NCRNA00011 | |NCRNA00011 | ||
|inactivation escape 2 (non-protein coding) | |inactivation escape 2 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''IRAIN'' | |''IRAIN'' | ||
Line 1,155: | Line 1,609: | ||
|IGF1R-AS | |IGF1R-AS | ||
|IGF1R antisense imprinted non-protein coding RNA | |IGF1R antisense imprinted non-protein coding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''JMJD1C-AS1'' | |''JMJD1C-AS1'' | ||
Line 1,165: | Line 1,614: | ||
|N/A | |N/A | ||
|JMJD1C antisense RNA 1 | |JMJD1C antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''KCNK15-AS1'' | |''KCNK15-AS1'' | ||
Line 1,195: | Line 1,629: | ||
|BWRT, HSA404617 | |BWRT, HSA404617 | ||
|KCNQ1 downstream neighbor (non-protein coding) | |KCNQ1 downstream neighbor (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''KIAA1614-AS1'' | |''KIAA1614-AS1'' | ||
Line 1,210: | Line 1,639: | ||
|HGC6.1.1 | |HGC6.1.1 | ||
|KIF25 antisense RNA 1 | |KIF25 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LAMP5-AS1'' | |''LAMP5-AS1'' | ||
Line 1,280: | Line 1,704: | ||
|N/A | |N/A | ||
|long intergenic non-protein coding RNA 161 | |long intergenic non-protein coding RNA 161 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00165'' | |''LINC00165'' | ||
Line 1,380: | Line 1,799: | ||
|MGC22001 | |MGC22001 | ||
|long intergenic non-protein coding RNA 311 | |long intergenic non-protein coding RNA 311 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00313'' | |''LINC00313'' | ||
Line 1,555: | Line 1,969: | ||
|Yiya, PROX1UT | |Yiya, PROX1UT | ||
|long intergenic non-protein coding RNA 538 | |long intergenic non-protein coding RNA 538 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00575'' | |''LINC00575'' | ||
Line 1,565: | Line 1,974: | ||
|N/A | |N/A | ||
|long intergenic non-protein coding RNA 575 | |long intergenic non-protein coding RNA 575 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00588'' | |''LINC00588'' | ||
Line 1,585: | Line 1,989: | ||
|TTL | |TTL | ||
|long intergenic non-protein coding RNA 598 | |long intergenic non-protein coding RNA 598 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00608'' | |''LINC00608'' | ||
Line 1,720: | Line 2,119: | ||
|N/A | |N/A | ||
|long intergenic non-protein coding RNA 839 | |long intergenic non-protein coding RNA 839 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00852'' | |''LINC00852'' | ||
Line 1,730: | Line 2,124: | ||
|NAG73, GHRL-AS2 | |NAG73, GHRL-AS2 | ||
|long intergenic non-protein coding RNA 852 | |long intergenic non-protein coding RNA 852 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC00854'' | |''LINC00854'' | ||
Line 1,995: | Line 2,384: | ||
|FLJ16341 | |FLJ16341 | ||
|long intergenic non-protein coding RNA 1185 | |long intergenic non-protein coding RNA 1185 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINC01192'' | |''LINC01192'' | ||
Line 2,315: | Line 2,699: | ||
|N/A | |N/A | ||
|long intergenic non-protein coding RNA, muscle differentiation 1 | |long intergenic non-protein coding RNA, muscle differentiation 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LINGO1-AS1'' | |''LINGO1-AS1'' | ||
Line 2,335: | Line 2,709: | ||
|N/A | |N/A | ||
|LMCD1 antisense RNA 1 (head to head) | |LMCD1 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LOH12CR2'' | |''LOH12CR2'' | ||
Line 2,365: | Line 2,734: | ||
|MGC40157 | |MGC40157 | ||
|LRRC75A antisense RNA 1 | |LRRC75A antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LUADT1'' | |''LUADT1'' | ||
Line 2,375: | Line 2,739: | ||
|N/A | |N/A | ||
|lung adenocarcinoma associated transcript 1 | |lung adenocarcinoma associated transcript 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''LUNAR1'' | |''LUNAR1'' | ||
Line 2,405: | Line 2,764: | ||
|RP5-869M20.2 | |RP5-869M20.2 | ||
|MAGEA8 antisense RNA 1 (head to head) | |MAGEA8 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MAPKAPK5-AS1'' | |''MAPKAPK5-AS1'' | ||
Line 2,415: | Line 2,769: | ||
|FLJ39616 | |FLJ39616 | ||
|MAPKAPK5 antisense RNA 1 | |MAPKAPK5 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MCM3AP-AS1'' | |''MCM3AP-AS1'' | ||
Line 2,435: | Line 2,784: | ||
|N/A | |N/A | ||
|MEF2C antisense RNA 1 | |MEF2C antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MEG9'' | |''MEG9'' | ||
Line 2,465: | Line 2,804: | ||
|Myheart | |Myheart | ||
|myosin heavy chain-associated RNA transcript | |myosin heavy chain-associated RNA transcript | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIF-AS1'' | |''MIF-AS1'' | ||
Line 2,485: | Line 2,819: | ||
|TCONSN/A00015189 | |TCONSN/A00015189 | ||
|MYC-induced long noncoding RNA | |MYC-induced long noncoding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIR137HG'' | |''MIR137HG'' | ||
Line 2,495: | Line 2,824: | ||
|N/A | |N/A | ||
|MIR137 host gene | |MIR137 host gene | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIR17HG'' | |''MIR17HG'' | ||
Line 2,515: | Line 2,839: | ||
|N/A | |N/A | ||
|MIR210 host gene | |MIR210 host gene | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIR34AHG'' | |''MIR34AHG'' | ||
Line 2,535: | Line 2,849: | ||
|LINC00978, AGD2, AK001796 | |LINC00978, AGD2, AK001796 | ||
|MIR4435-2 host gene | |MIR4435-2 host gene | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIR600HG'' | |''MIR600HG'' | ||
Line 2,555: | Line 2,864: | ||
|PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 | |PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 | ||
|MIR7-3 host gene | |MIR7-3 host gene | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''MIRLET7BHG'' | |''MIRLET7BHG'' | ||
Line 2,600: | Line 2,904: | ||
|NCYM, N-CYM, MYCN-AS1 | |NCYM, N-CYM, MYCN-AS1 | ||
|MYCN opposite strand | |MYCN opposite strand | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''N4BP2L2-IT2'' | |''N4BP2L2-IT2'' | ||
Line 2,615: | Line 2,914: | ||
|TCONSN/Al2N/A00029132 | |TCONSN/Al2N/A00029132 | ||
|NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | |NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''NBAT1'' | |''NBAT1'' | ||
Line 2,640: | Line 2,934: | ||
|N/A | |N/A | ||
|NCOA7 antisense RNA 1 | |NCOA7 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''NCRUPAR'' | |''NCRUPAR'' | ||
Line 2,650: | Line 2,939: | ||
|ncR-uPAR, ncRuPAR, NCRNA00193 | |ncR-uPAR, ncRuPAR, NCRNA00193 | ||
|non-protein coding RNA, upstream of F2R/PAR1 | |non-protein coding RNA, upstream of F2R/PAR1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''NFIA-AS1'' | |''NFIA-AS1'' | ||
Line 2,720: | Line 2,999: | ||
|N/A | |N/A | ||
|negative regulator of antiviral response (non-protein coding) | |negative regulator of antiviral response (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''OLMALINC'' | |''OLMALINC'' | ||
Line 2,745: | Line 3,004: | ||
|bA34D15.5, FLJ12974, HI-LNC80 | |bA34D15.5, FLJ12974, HI-LNC80 | ||
|oligodendrocyte maturation-associated long intergenic non-coding RNA | |oligodendrocyte maturation-associated long intergenic non-coding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PANCR'' | |''PANCR'' | ||
Line 2,765: | Line 3,009: | ||
|N/A | |N/A | ||
|PITX2 adjacent non-coding RNA | |PITX2 adjacent non-coding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PAPPA-AS1'' | |''PAPPA-AS1'' | ||
Line 2,780: | Line 3,019: | ||
|AGU1 | |AGU1 | ||
|PAPPA antisense RNA 2 | |PAPPA antisense RNA 2 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PARTICL'' | |''PARTICL'' | ||
Line 2,790: | Line 3,024: | ||
|PARTICLE | |PARTICLE | ||
|promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | |promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PAXIP1-AS1'' | |''PAXIP1-AS1'' | ||
Line 2,800: | Line 3,029: | ||
|N/A | |N/A | ||
|PAXIP1 antisense RNA 1 (head to head) | |PAXIP1 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PCAT14'' | |''PCAT14'' | ||
Line 2,830: | Line 3,049: | ||
|N/A | |N/A | ||
|prostate cancer associated transcript 29 (non-protein coding) | |prostate cancer associated transcript 29 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PCAT5'' | |''PCAT5'' | ||
Line 2,840: | Line 3,054: | ||
|TPCAT-10-36067 | |TPCAT-10-36067 | ||
|prostate cancer associated transcript 5 (non-protein coding) | |prostate cancer associated transcript 5 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PCBP2-OT1'' | |''PCBP2-OT1'' | ||
Line 2,865: | Line 3,069: | ||
|ENST00000602322.1 | |ENST00000602322.1 | ||
|PCF11 anstisense RNA 1 | |PCF11 anstisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PCNA-AS1'' | |''PCNA-AS1'' | ||
Line 2,900: | Line 3,099: | ||
|NCRNA00195 | |NCRNA00195 | ||
|polled intersex syndrome regulated transcript 1 (non-protein coding RNA) | |polled intersex syndrome regulated transcript 1 (non-protein coding RNA) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PRKCQ-AS1'' | |''PRKCQ-AS1'' | ||
Line 2,915: | Line 3,104: | ||
|ENST00000414894.1 | |ENST00000414894.1 | ||
|PRKCQ antisense RNA 1 | |PRKCQ antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PRR7-AS1'' | |''PRR7-AS1'' | ||
Line 2,935: | Line 3,119: | ||
|N/A | |N/A | ||
|PSMD5 antisense RNA 1 (head to head) | |PSMD5 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PTENP1-AS'' | |''PTENP1-AS'' | ||
Line 2,965: | Line 3,129: | ||
|N/A | |N/A | ||
|PTPRJ antisense RNA 1 | |PTPRJ antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''PWAR1'' | |''PWAR1'' | ||
Line 2,990: | Line 3,149: | ||
|PAR-SN, PARSN | |PAR-SN, PARSN | ||
|Prader Willi/Angelman region RNA, SNRPN neighbor | |Prader Willi/Angelman region RNA, SNRPN neighbor | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''RAD51-AS1'' | |''RAD51-AS1'' | ||
Line 3,005: | Line 3,154: | ||
|TODRA | |TODRA | ||
|RAD51 antisense RNA 1 (head to head) | |RAD51 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''RFPL1S'' | |''RFPL1S'' | ||
Line 3,090: | Line 3,229: | ||
|FLJ38109, GALNT10-AS1 | |FLJ38109, GALNT10-AS1 | ||
|SAP30L antisense RNA 1 (head to head) | |SAP30L antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''SEC24B-AS1'' | |''SEC24B-AS1'' | ||
Line 3,105: | Line 3,234: | ||
|1/2-SBSRNA4 | |1/2-SBSRNA4 | ||
|SEC24B antisense RNA 1 | |SEC24B antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''SGMS1-AS1'' | |''SGMS1-AS1'' | ||
Line 3,155: | Line 3,279: | ||
|MGC23284 | |MGC23284 | ||
|SNAI3 antisense RNA 1 | |SNAI3 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''SNHG10'' | |''SNHG10'' | ||
Line 3,200: | Line 3,314: | ||
|PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG | |PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG | ||
|small nucleolar RNA host gene 20 | |small nucleolar RNA host gene 20 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''SNHG7'' | |''SNHG7'' | ||
Line 3,250: | Line 3,344: | ||
|N/A | |N/A | ||
|SPATA3 antisense RNA 1 (head to head) | |SPATA3 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ST7-AS1'' | |''ST7-AS1'' | ||
Line 3,270: | Line 3,354: | ||
|ST7AS2 | |ST7AS2 | ||
|ST7 antisense RNA 2 | |ST7 antisense RNA 2 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ST7-OT3'' | |''ST7-OT3'' | ||
Line 3,290: | Line 3,369: | ||
|LOC100507266 | |LOC100507266 | ||
|STX18 antisense RNA 1 (head to head) | |STX18 antisense RNA 1 (head to head) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TCL6'' | |''TCL6'' | ||
Line 3,305: | Line 3,379: | ||
|LINC00532, lincRNA-NRN/A024015 | |LINC00532, lincRNA-NRN/A024015 | ||
|testis development related 1 (non-protein coding) | |testis development related 1 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TEX41'' | |''TEX41'' | ||
Line 3,340: | Line 3,409: | ||
|TD1, TDI, APT-B7 | |TD1, TDI, APT-B7 | ||
|TLX1 neighbor | |TLX1 neighbor | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TMEM92-AS1'' | |''TMEM92-AS1'' | ||
Line 3,355: | Line 3,419: | ||
|N/A | |N/A | ||
|TMEM9B antisense RNA 1 | |TMEM9B antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TOLLIP-AS1'' | |''TOLLIP-AS1'' | ||
Line 3,440: | Line 3,499: | ||
|NCRNA00132 | |NCRNA00132 | ||
|testis-specific transcript, Y-linked 9B (non-protein coding) | |testis-specific transcript, Y-linked 9B (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TUNAR'' | |''TUNAR'' | ||
Line 3,450: | Line 3,504: | ||
|TUNA, HI-LNC78 | |TUNA, HI-LNC78 | ||
|TCL1 upstream neural differentiation-associated RNA | |TCL1 upstream neural differentiation-associated RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''TUSC8'' | |''TUSC8'' | ||
Line 3,460: | Line 3,509: | ||
|XLOCN/A010588 | |XLOCN/A010588 | ||
|tumor suppressor candidate 8 (non-protein coding) | |tumor suppressor candidate 8 (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''UMODL1-AS1'' | |''UMODL1-AS1'' | ||
Line 3,490: | Line 3,534: | ||
|FBI4 | |FBI4 | ||
|WDFY3 antisense RNA 2 | |WDFY3 antisense RNA 2 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''WSPAR'' | |''WSPAR'' | ||
Line 3,500: | Line 3,539: | ||
|TCONSN/A00009511-XLOCN/A004555, lncTCF7 | |TCONSN/A00009511-XLOCN/A004555, lncTCF7 | ||
|WNT signaling pathway activating non-coding RNA | |WNT signaling pathway activating non-coding RNA | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''XACT'' | |''XACT'' | ||
Line 3,510: | Line 3,544: | ||
|N/A | |N/A | ||
|X active specific transcript (non-protein coding) | |X active specific transcript (non-protein coding) | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''YAM1'' | |''YAM1'' | ||
Line 3,535: | Line 3,559: | ||
|N/A | |N/A | ||
|ZEB1 antisense RNA 1 | |ZEB1 antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ZFAT-AS1'' | |''ZFAT-AS1'' | ||
Line 3,550: | Line 3,564: | ||
|SAS-ZFAT, NCRNA00070 | |SAS-ZFAT, NCRNA00070 | ||
|ZFAT antisense RNA 1 | |ZFAT antisense RNA 1 | ||
− | |||
− | |||
− | |||
− | |||
− | |||
|- | |- | ||
|''ZIM2-AS1'' | |''ZIM2-AS1'' |
Revision as of 05:50, 25 June 2016
Name | Transcript ID | Alias | Description | ||||
---|---|---|---|---|---|---|---|
21A | NONHSAT128494 | ncRNA 21A | N/A | ||||
7SK | NONHSAT113149 | 7-3 RNA, K-RNA, 7SK-RNA, 7SK snRNA, RN7SK, ENSG00000202198 | RNA, 7SK small nuclear | ||||
7SL | lnc-LRR1-1:1 | 7S RNA, SRP RNA, 4.5S SRP RNA, 4.5S RNA, RN7SL1 RNA, ENSG00000258486 | RNA, 7SL, cytoplasmic 1 | ||||
ABALON | ABALON | INXS | apoptotic BCL2L1-antisense long non-coding RNA | ||||
AIRN | ENST00000609176.1 | AIRN, AIRN, IGF2RAS | Antisense of IGF2R non-protein coding RNA | ||||
APOA1-AS | ENST00000444200.1 | APOA1 antisense RNA | N/A | ||||
APTR | NONHSAT121673 | Alu-mediated CDKN1A/p21 | N/A | ||||
BANCR | Lnc-APBA1-3:1 | LINC00586 | BRAF-activated non-protein coding RNA | ||||
BDNF-AS | ENST00000499008.3 | BDNF antisense RNA | BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049 | ||||
BLACAT1 | BLACAT1 | linc-UBC1,LINC00912, onco-lncRNA-30 | bladder cancer associated transcript 1 (non-protein coding) | ||||
CAHM | ENST00000604200.1 | LINC00468 | colon adenocarcinoma hypermethylated (non-protein coding) | ||||
PTCSC1 | NONHSAT129210 | AK023948 | papillary thyroid carcinoma susceptibility candidate 1 (non-protein coding) | ||||
BCYRN1 | lnc-EPCAM-1:2 | BC200,BC200a, NCRNA00004, LINC00004 | BCYRN1, brain cytoplasmic RNA 1 | ||||
BPESC1 | ENST00000418282.1 | NCRNA00187 | blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding) | ||||
CYP4A22-AS1 | ENST00000444042.2 | Noncoding RNA activating3: ncRNA-a3, ENST00000444042.2, ENSG00000225506 | CYP4A22 antisense RNA 1 | ||||
CASC8 | CASC8 | LINC00860,CARLo-1 | cancer susceptibility candidate 8 (non-protein coding) | ||||
CCAT1 | NONHSAT129017 | CARLo-5, onco-lncRNA-40 | colon cancer associated transcript 1 (non-protein coding) | ||||
CCAT2 | CCAT2 | NCCP1, LINC00873 | colon cancer associated transcript 2 (non-protein coding) | ||||
CISTR | NONHSAT028496 | CISTR-ACT, CISTRACT, re52431 | chondrogenesis-associated transcript | ||||
CRNDE | Lnc-IRX3-4:2 | LOC643911, LINC00180, CRNDEP | colorectal neoplasia differentially expressed (non-protein coding) | ||||
CYYR1-AS1 | ENST00000357401.3 | cysteine and tyrosine rich 1 antisense RNA 1 | N/A | ||||
DALIR | DALIR | DALI | DNMT1-associated long intergenic non-coding RNA | ||||
DANCR | NONHSAT096369 | differentiation antagonizing non-protein coding RNA | ANCR, AGU2, lncRNA-ANCR | ||||
DBET | NONHSAT099821 | DBE-T, DUX4L30 | D4Z4 binding element transcript (non-protein coding) | ||||
DHFR upstream transcripts | NONHSAT102417 | DHFR minor transcript 5'-UTR, ENSG00000228716 | N/A | ||||
DHRS4-AS1 | NONHSAT035954 | DHRS4 antisense RNA 1 | PRO1488,AS1DHRS4 | ||||
DLEU1 | NONHSAT033797 | deleted in lymphocytic leukemia 1 (non-protein coding) | LEU1, XTP6, NCRNA00021, LINC00021, BCMS1 | ||||
DLEU2 | NONHSAT033821 | deleted in lymphocytic leukemia 2 (non-protein coding) | LEU2, TRIM13OS, NCRNA00022, LINC00022, MIR15AHG | ||||
DISC2 | NONHSAT010191 | DISC1-AS1, DISC1OS, NCRNA00015 | disrupted in schizophrenia 2 (non-protein coding) | ||||
EGOT | NONHSAT087635 | EGO, "eosinophil granule ontogeny", NCRNA00190, "non-protein coding RNA 190", ENSG00000235947 | Eosinophil granule ontogeny (EGO) RNA | ||||
EMX2OS | lnc-PDZD8-3:1 | EMX2-AS1, NCRNA00045, "non-protein coding RNA 45",ENSG00000229847 | Emx2 opposite strand transcript. | ||||
ERICD | Lnc-CHRAC1-2:1 | TCONS_00014875, ERIC | E2F1-regulated inhibitor of cell death (non-protein coding) | ||||
ESRG | ENST00000583516.1 | HESRG | embryonic stem cell related (non-protein coding) | ||||
Evf2 | lnc-DLX5-3:1 | Evf-2, Dlx6as1, Dlx6os1, ENSG00000231764 | |||||
FENDRR | FENDRR | FOXF1 adjacent non-coding developmental regulatory RNA | lincFOXF1, onco-lncRNA-21 | ||||
FIRRE | ENST00000427391.1 | firre intergenic repeating RNA element | LINC01200 | ||||
FOXCUT | Lnc-FOXC1-1:1,NONHSAT106529 | TCONS_00011636 | FOXC1 upstream transcript (non-protein coding) | ||||
FTX | ENST00000602812.1 | LINC00182,FLJ33139 | FTX transcript, XIST regulator (non-protein coding) | ||||
GHET1 | GHET1 | lncRNA-GHET1 | gastric carcinoma proliferation enhancing transcript 1 | ||||
GHRLOS | NONHSAT087920 | NCRNA00068,GHRL-AS1 | ghrelin opposite strand/antisense RNA | ||||
GPR1-AS | NONHSAT076558 | GPR1AS | GPR1 antisense RNA | ||||
HAGLR | ENST00000416928.2,NONHSAT075638 | Mdgt | HOXD antisense growth-associated long non-coding RNA | ||||
HEIH | HEIH | LINC-HEIH, lncRNA-HEIH, LINC00848, HCCAT2 | hepatocellular carcinoma up-regulated EZH2-associated long non-coding RNA | ||||
JADRR | JADRR | lncRNA-JADE | JADE1 adjacent regulatory RNA | ||||
KANTR | ENST00000604849.1 | KDM5C adjacent non-coding transcript | Spasm | ||||
LINC-PINT | NONHSAT123382 | FLJ43663, PINT, LincRNA-Pint | long intergenic non-protein coding RNA, p53 induced transcript | ||||
LINC00163 | LINC00163 | NLC1-A, NLC1A | long intergenic non-protein coding RNA 163 | ||||
LINC00312 | NONHSAT087716 | NAG7, NAG-7, ERR10, LMCD1DN, ERR-10 | long intergenic non-protein coding RNA 312 | ||||
LINC00850 | LINC00850 | KUCG1 | long intergenic non-protein coding RNA 850 | ||||
LINC01191 | ENST00000412690.1 | VIN, lnc-ACTR3 | long intergenic non-protein coding RNA 1191 | ||||
LSINCT5 | LSINCT5 | N/A | long stress-induced non-coding transcript 5 | ||||
LUCAT1 | ENST00000511918.1 | SCAL1 | lung cancer associated transcript 1 (non-protein coding) | ||||
MIR22HG | ENST00000574306.1 | MGC14376, DKFZp686O06159, LOC554202 | MIR22 host gene | ||||
MIR31HG | NONHSAT130385 | LOC554202 | MIR31 host gene | ||||
MIR99AHG | ENST00000602580.1 | MONC | mir-99a-let-7c cluster host gene | ||||
MIR100HG | ENST00000531381.1 | AGD1, lncRNA-N2 | mir-100-let-7a-2 cluster host gene | ||||
MIR155HG | NONHSAT081499 | BIC, NCRNA00172 | MIR155 host gene | ||||
MIR222HG | ENST00000602507.1 | Lnc-Ang362 | MIR222 host gene | ||||
MIR503HG | ENST00000414769.1 | MGC16121, H19X | MIR503 host gene | ||||
MYCNUT | ENST00000433810.1 | lncUSMycN | MYCN upstream transcript (non-protein coding) | ||||
NAMA | ENST00000604258.1 | N/A | non-protein coding RNA, associated with MAP kinase pathway and growth arrest | ||||
NRIR | ENST00000414795.1 | lncRNA-CMPK2 | negative regulator of interferon response (non-protein coding) | ||||
OIP5-AS1 | ENST00000500949.2 | cyrano,LOC729082, linc-NUSAP1-1, OIP5-AS1 | OIP5 antisense RNA 1 | ||||
OVAAL | ENST00000442621.1 | LINC01131,OVAL | ovarian adenocarcinoma amplified long non-coding RNA | ||||
PACERR | ENST00000608917.1 | PACER, PTGS2-AS1 | PTGS2 antisense NFKB1 complex-mediated expression regulator RNA | ||||
PART1 | ENST00000506884.1 | DKFZP586D0823, NCRNA00206 | prostate androgen-regulated transcript 1 (non-protein coding) | ||||
PAUPAR | NONHSAT018635 | N/A | PAX6 upstream antisense RNA | ||||
PCA3 | ENST00000412654.1 | DD3, NCRNA00019, PCAT3 | prostate cancer associated 3 (non-protein coding) | ||||
PCAT1 | ENST00000561978.1 | PCAT-1, PCA1 | prostate cancer associated transcript 1 (non-protein coding) | ||||
PCAT4 | ENST00000504263.1 | GDEP, PCAN1, PCA4 | prostate cancer associated transcript 4 (non-protein coding) | ||||
PCAT7 | ENST00000452148.2 | PCAN-R2 | prostate cancer associated transcript 7 (non-protein coding) | ||||
PRNCR1 | NONHSAT129019 | N/A | prostate cancer associated non-coding RNA 1 | ||||
PTCSC2 | ENST00000430058.1 | N/A | papillary thyroid carcinoma susceptibility candidate 2 (non-protein coding) | ||||
PTCSC3 | ENST00000556013.2 | N/A | papillary thyroid carcinoma susceptibility candidate 3 (non-protein coding) | ||||
PVT1 | ENST00000513868.2 | NCRNA00079, LINC00079, onco-lncRNA-100 | Pvt1 oncogene (non-protein coding) | ||||
PWRN1 | NONHSAT040920 | NCRNA00198 | Prader-Willi region non-protein coding RNA 1 | ||||
PWRN2 | NONHSAT040875 | NCRNA00199 | Prader-Willi region non-protein coding RNA 2 | ||||
RASSF1-AS1 | RASSF1-AS1 | RASSF1 antisense RNA 1 | ANRASSF1 | ||||
SCAANT1 | SCAANT1 | SCA7/ATXN7 antisense RNA 1 | ATXN7-AS1 | ||||
SCHLAP1 | NONHSAT075852 | SWI/SNF complex antagonist associated with prostate cancer 1 (non-protein coding) | SChLAP1,PCAT11 | ||||
SENCR | ENST00000526269.2 | smooth muscle and endothelial cell enriched migration/differentiation-associated long non-coding RNA | N/A | ||||
TARID | ENST00000607033.1 | N/A | TCF21 antisense RNA inducing promoter demethylation | ||||
WFDC21P | Lnc-HEATR6-1:4 | WAP four-disulfide core domain 21, pseudogene | LOC645638, lnc-DC, LNCDC | ||||
GAS5 | NONHSAT007663 | SNHG2, ENSG00000234741 | |||||
MIAT | lnc-CRYBA4-2:1 | FLJ25967, gomafu, LINC00066, lncRNA-MIAT, "long intergenic non-protein coding RNA 66", NCRNA00066, "non-protein coding RNA 66", Rncr2 | myocardial infarction associated transcript (non-protein coding) | ||||
H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | H19, imprinted maternally expressed transcript (non-protein coding) | ||||
HAR1A | lnc-BIRC7-2:1 | HAR1F, ENSG00000238820 | highly accelerated region 1A | ||||
HAR1B | ENST00000447910.2 | HAR1R, ENSG00000231133 | highly accelerated region 1B | ||||
HOTAIR | NONHSAT028508 | Gm16258, Hox antisense intergenic RNA, ENSG00000228630 | Hox antisense intergenic RNA | ||||
HOTAIRM1 | lnc-EVX1-12:1 | HIT06113, HIT92376, linc1548, ENSG00000233429 | HOXA transcript antisense RNA, myeloid-specific 1 | ||||
HOTTIP | NONHSAT119717 | HOXA13as, HIT18844, NCRNA00213, ENSG00000243766 | HOXA transcript at the distal tip | ||||
HOXA11-AS | NONHSAT119704 | "HOXA cluster antisense RNA 5 (non-protein coding)", HOXA-AS5, "HOXA11 antisense RNA 1 (non-protein coding)", HOXA11-AS1, HOXA11S, NCRNA00076, "non-protein coding RNA 76", ENSG00000240990 | HOXA11 antisense RNA | ||||
HOXA-AS2 | NONHSAT119676 | HOXA3as, ENSG00000253552 | HOXA cluster antisense RNA 2 | ||||
HOXA-AS3 | lnc-EVX1-9:1 | HOXA6as | HOXA cluster antisense RNA 3 | ||||
HULC | NONHSAT107640 | ENSG00000251164 | hepatocellular carcinoma up-regulated long non-coding RNA | ||||
IPW | NONHSAT041063 | NCRNA00002 | imprinted in Prader-Willi syndrome | ||||
JPX | lnc-ZCCHC13-1:1 | DCBALD06, ENOX, "expressed neighbor of XIST", "just proximal to XIST", LINC00183 | JPX transcript, XIST activator (non-protein coding) | ||||
KCNQ1OT1 | NONHSAT017524 | "KCNQ1 antisense RNA 2 (non-protein coding)", "KCNQ1 overlapping transcript 1 (non-protein coding)", KCNQ1-AS2, KvDMR1, KvLQT1-AS, LIT1, NCRNA00012, "non-protein coding RNA 12" | KCNQ1 opposite strand/antisense transcript 1 (non-protein coding) | ||||
KRASP1 | NONHSAT113225 | ENSG00000220635 | KRAS Pseudogene 1 | ||||
FALEC | ENST00000416894.1 | LINC00568, "long intergenic non-protein coding RNA 568", ENSG00000228126.1 | focally amplified long non-coding RNA in epithelial cancer | ||||
lincRNA-ROR | NONHSAT059436 | ROR, lincRNA-ST8SIA3, ENSG00000258609 | long intergenic non-protein coding RNA, regulator of reprogramming | ||||
LOC100887755 | lnc-SNAI1-1:1 | Noncoding RNA activating7: ncRNA-a7, ENST00000431460.1,ENSG00000231265,TRERNA1 | translation regulatory long non-coding RNA 1 | ||||
TUSC7 | NONHSAT091315 | LINC00902, LOC285194, ENSG00000243197 | tumor suppressor candidate 7 (non-protein coding) | ||||
RBM5-AS1 | NONHSAT089783 | "LUCA-15-specific transcript", LUST, ENSG00000003756 | RBM5 antisense RNA 1 | ||||
MALAT1 | ENST00000534336.1 | HCN, "hepcarcin", LINC00047, "long intergenic non-protein coding RNA 47", MALAT-1, mascRNA, "metastasis associated in lung adenocarcinoma transcript 1", NCRNA00047, NEAT2, "non-protein coding RNA 47", "nuclear enriched abundant transcript 2", "nuclear paraspeckle assembly transcript 2 (non-protein coding)", PRO1073, ENSG00000251562 | metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) | ||||
mascRNA | lnc-SCYL1-1:5 | Malat1 | mascRNA (MALAT1-associated small cytoplasmic RNA) | ||||
MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | ||||
ncR-PAR | NONHSAT102247 | NCRUPAR, ENSG00000225407 | non-protein coding RNA, upstream of F2R/PAR1 | ||||
NDM29 | lnc-C11orf16-1:1 | 29A | neuroblastoma differentiation marker 29 (Castelnuovo (2010), Pagano (2007)). | ||||
GNAS-AS1 | lnc-CTSZ-5:1 | "GNAS antisense", GNAS1AS, NCRNA00075, NESP-AS, NESPAS, "non-protein coding RNA 75", SANG, ENSG00000235590 | neuroendocrine secretory protein (Nesp) antisense. | ||||
NRON | NONHSAT134764 | ENSG00000253079 | non-protein coding RNA, repressor of NFAT | ||||
NTT | NONHSAT115106 | noncoding transcript in T cells. | |||||
OTX2-AS1 | lnc-C14orf101-5:1 | OTX2OS1, ENSG00000248550 | OTX2 antisense RNA 1 (head to head) | ||||
PANDAR | lnc-CDKN1A-1:1 | P21 associated ncRNA DNA damage activated, PANDA antisense RNA, ENSG00000213500, PANDAR | promoter of CDKN1A antisense DNA damage activated RNA | ||||
PCGEM1 | NONHSAT076153 | ENSG00000227418; PCAT9; LINC00071; NCRNA00071 lncRNA | Prostate-specific transcript 1 | ||||
LINC00853 | ENST00000429328.2 | "PDZK1IP1 antisense RNA 1 (non-protein coding)", "PDZK1IP1 antisense RNA 1 (tail to tail)", PDZK1IP1-AS1 ,ENSG00000224805 | long intergenic non-protein coding RNA 853 | ||||
PRINS | NONHSAT011777 | ENSG00000238115 | Psoriasis susceptibility-related RNA Gene Induced by Stress | ||||
PTENP1 | NONHSAT130775 | PTENpg1, PTEN2, ENSG00000237984 | PTEN Pseudogene 1 | ||||
MEG8 | ENST00000553584.1 | Bsr, "Imprinted RNA near Meg3/Gtl2", Irm, LINC00024, "long intergenic non-protein coding RNA 24", NCRNA00024, "non-protein coding RNA 24", Rian, "RNA Imprinted and Accumulated in Nucleus", ENSG00000258399 | Rian: RNA Imprinted and Accumulated in Nucleus;Irm: Imprinted RNA near Meg3/Gtl2;MEG8: Maternally expressed gene 8 | ||||
LINC00599 | lnc-TNKS-1:1 | "retinal non-coding RNA 3", Rncr3, ENSG00000253230 | Retinal noncoding RNA 3, long intergenic non-protein coding RNA 599 | ||||
FAS-AS | NONHSAT015489 | SAF, ENSG00000026103 | FAS antisense RNA 1 | ||||
ATXN8OS | NONHSAT034251 | NCRNA00003, "non-protein coding RNA 3", ATXN8OS, KLHL1AS, SCA8, ENSG00000230223 | Spinocerebellar ataxia 8 (SCA8) RNA;KLHL1AS: kelch-like 1 (Drosophila) antisense;ATXN8OS: ataxin 8 opposite strand | ||||
SNHG1 | NONHSAT021826 | UHG, ENSG00000255717 | SNHG1:Small nucleolar RNA host gene 1;UHG: U22 host gene. | ||||
SNHG3 | lnc-OR10H5-1:1 | U17HG, linc1343, ENSG00000242125 | Small nucleolar RNA host gene 3 | ||||
SNHG4 | NONHSAT104072 | U19H, ENSG00000200959 | Small nucleolar RNA host gene 4 | ||||
SNHG5 | NONHSAT054526 | U50HG, ENSG00000203875 | Small nucleolar RNA host gene 5 | ||||
SNHG6 | lnc-TCF24-2:3 | U87HG, ENSG00000245910 | Small nucleolar RNA host gene 6 | ||||
SPRY4-IT1 | lnc-NDFIP1-3:1 | AK024556, ENSG00000274721 | SPRY4 intronic transcript 1 (non-protein coding) | ||||
SRA | lnc-SRA1-1:1 | SRA1, ENSG00000213523 | Steroid receptor RNA Activator | ||||
TEA-ncRNAs | NONHSAT035776 | ENSG00000251002 | T early alpha | ||||
IFNG-AS1 | ENST00000538665.1 | LincR-Ifng-3'AS, NEST, "Theiler's murine encephalomyelitis virus persistence candidate gene 1", Tmevpg1, ENSG00000255733 | IFNG antisense RNA 1 | ||||
TncRNA | NONHSAT022116 | TSU | TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | ||||
TUG1 | NONHSAT084827 | ENSG00000253352 | taurine up-regulated gene 1 (Young (2005)). | ||||
UCA1 | lnc-OR10H5-1:1 | UCA1a, CUDR, UCAT1, LINC00178, NCRNA00178, GCAP2, GUCA1B, GUCA2, RP48, ENSG00000214049 | urothelial cancer associated 1 (non-protein coding) | ||||
KCNIP4-IT1 | NONHSAT095745 | "non coding transcript UM9(5)", UM9-5 | KCNIP4 intronic transcript 1 (non-protein coding) | ||||
WT1-AS | lnc-EIF3M-1:1 | WIT1, ENSG00000183242 | WT1 (Wilms' tumor 1) antisense transcript | ||||
XIST | NONHSAT137541 | ENSG00000229807 | X inactive-specific transcript | ||||
ZEB2-AS1 | NONHSAT074775 | Zeb2NAT, ENSG00000238057 | Zeb2 natural antisense transcript | ||||
ZFAS1 | NONHSAT080206 | Znfx1 antisense, 1500012F01Rik, NCRNA00275, ENSG00000177410 | ZNFX1 antisense RNA 1 | ||||
Zfhx2as | ENST00000554403.1 | Zfh-5AS, ENSG00000157306 | zinc finger homeobox 2, antisense | ||||
TMEM161B-AS1 | lnc-RASA1-3:23,lnc-RASA1-3:25 | AK082072,linc-POLR3G-8, ENSG00000247828 | TMEM161B antisense RNA 1 | ||||
Alpha 250/ Alpha 280 | NONHSAT104559,lnc-NDST1-1:2 | N/A | N/A | ||||
CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | ANRIL, p15AS, ENSG00000240498 | CDKN2B antisense RNA 1 | ||||
BACE1-AS | NONHSAT024403,lnc-RNF214-1:2 | BACE1AS,NCRNA00177; FJ573250 | BACE1 antisense RNA | ||||
Beta-globin transcripts | NONHSAT017676,NONHSAT017675,NONHSAT017674 | N/A | N/A | ||||
LINC00581 | lnc-PRL-6:2,lnc-PRL-6:1 | BX118339,Hs.112750, linc-MBOAT1-4: TCONS_00012107, linc-MBOAT1-4: TCONS_00012678 | long intergenic non-protein coding RNA 581 | ||||
CAR Intergenic 10 | NONHSAT016928,lnc-FANK1-3:1 | Intergenic10, CR611911, AK055628 | Chromatin Associated RNA 10 | ||||
DIO3OS | NONHSAT040032,NONHSAT040039 | DIO3-AS1, NCRNA00041, "non-protein coding RNA 41", ENSG00000258498 | DIO3 opposite strand/antisense RNA (head to head) | ||||
PCAT6 | ENST00000425295.1,ENST00000553157.1,ENST00000417262.1 | Noncoding RNA activating2: ncRNA-a2, KDM5B antisense RNA 1 (KDM5B-AS1),, ENSG00000228288 | N/A | ||||
LINC00570 | ENST00000437795.1,ENST00000432665.1,ENST00000453100.1,ENST00000417473.2 | KDM5BAS1, ncRNA-a2, onco-lncRNA-96, PCAN-R1, "prostate cancer-associated noncoding RNA 1",ENSG00000224177, | prostate cancer associated transcript 6 (non-protein coding) | ||||
NEAT1 | ENST00000501122.2,NONHSAT022111 | MEN epsilon/beta, VINC, TncRNA, linc1317, ENSG00000245532 | Nuclear enriched abundant transcript 1. | ||||
ST7OT | NONHSAT122926,NONHSAT122918,NONHSAT122914,NONHSAT122932 | ST7OT1, ST7OT2, ST7OT3, ST7OT4, ST7AS1, ST7AS2, ST7AS3, ST7AS4, ENSG00000214188 | N/A | ||||
snaR | lnc-BSPH1-1:1,lnc-BSPH1-2:1 | small NF90-associated RNAs | small NF90-associated RNAs | ||||
Y RNAs | lnc-PDIA4-1:1 | N/A | N/A | ||||
PR antisense transcripts | NONHSAT023851 | N/A | N/A | FAM3D-AS1 | FAM3D-AS1 | lnc-KCTD6-3 | FAM3D antisense RNA 1 |
SHANK2-AS3 | SHANK2-AS3 | N/A | SHANK2 antisense RNA 3 | ||||
AATBC | AATBC | N/A | apoptosis associated transcript in bladder cancer | ||||
ABHD11-AS1 | ABHD11-AS1 | NCRNA00035 | ABHD11 antisense RNA 1 (tail to tail) | ||||
ABHD15-AS1 | ABHD15-AS1 | linc-TP53I13, lnc-TP53I13 | ABHD15 antisense RNA 1 | ||||
ACTA2-AS1 | ACTA2-AS1 | uc001kfo.1, ZXF1 | ACTA2 antisense RNA 1 | ||||
ADAMTS9-AS2 | ADAMTS9-AS2 | N/A | ADAMTS9 antisense RNA 2 | ||||
ADORA2A-AS1 | ADORA2A-AS1 | FLJ34651 | ADORA2A antisense RNA 1 | ||||
AFAP1-AS1 | AFAP1-AS1 | MGC10981 | AFAP1 antisense RNA 1 | ||||
AGAP2-AS1 | AGAP2-AS1 | LOC100130776, PUNISHER | AGAP2 antisense RNA 1 | ||||
Alpha 250/Alpha 280 | NONHSAT104559,lnc-NDST1-1:2 | N/A | N/A | ||||
ANP32A-IT1 | ANP32A-IT1 | FLJ11722, HsT18971 | ANP32A intronic transcript 1 | ||||
ARRDC1-AS1 | ARRDC1-AS1 | N/A | ARRDC1 antisense RNA 1 | ||||
ASAP1-IT1 | ASAP1-IT1 | HSPC054, NCRNA00050, ASAP1IT, ASAP1-IT | ASAP1 intronic transcript 1 | ||||
ASMTL-AS1 | ASMTL-AS1 | FLJ13330 | ASMTL antisense RNA 1 | ||||
ATP1A1-AS1 | ATP1A1-AS1 | MGC16179 | ATP1A1 antisense RNA 1 | ||||
B3GALT5-AS1 | B3GALT5-AS1 | N/A | B3GALT5 antisense RNA 1 | ||||
B4GALT1-AS1 | B4GALT1-AS1 | N/A | B4GALT1 antisense RNA 1 | ||||
BAALC-AS2 | BAALC-AS2 | MGC39526 | BAALC antisense RNA 2 | ||||
BCAR4 | BCAR4 | N/A | breast cancer anti-estrogen resistance 4 (non-protein coding) | ||||
BFSP2-AS1 | BFSP2-AS1 | MGC2848 | BFSP2 antisense RNA 1 | ||||
BGLT3 | BGLT3 | LINC01083, BGL3, lncRNA-BGL3 | beta globin locus transcript 3 (non-protein coding) | ||||
BIN3-IT1 | BIN3-IT1 | FLJ14107 | BIN3 intronic transcript 1 | ||||
BIRC6-AS1 | BIRC6-AS1 | N/A | BIRC6 antisense RNA 1 | ||||
BIRC6-AS2 | BIRC6-AS2 | megamind | BIRC6 antisense RNA 2 | ||||
BISPR | BISPR | N/A | BST2 interferon stimulated positive regulator (non-protein coding) | ||||
BOK-AS1 | BOK-AS1 | NCRNA00151, NAToB | BOK antisense RNA 1 | ||||
BRWD1-AS2 | BRWD1-AS2 | N/A | BRWD1 antisense RNA 2 | ||||
C1QTNF9B-AS1 | C1QTNF9B-AS1 | PCOTH | C1QTNF9B antisense RNA 1 | ||||
C21orf91-OT1 | C21orf91-OT1 | D21S2089E | C21orf91 overlapping transcript 1 | ||||
C5orf66-AS1 | C5orf66-AS1 | CTC-276P9.1, Epist | C5orf66 antisense RNA 1 | ||||
C5orf66-AS2 | C5orf66-AS2 | N/A | C5orf66 antisense RNA 2 | ||||
C8orf34-AS1 | C8orf34-AS1 | N/A | C8orf34 antisense RNA 1 | ||||
CACNA1G-AS1 | CACNA1G-AS1 | N/A | CACNA1G antisense RNA 1 | ||||
CAPN10-AS1 | CAPN10-AS1 | locus959 | CAPN10 antisense RNA 1 (head to head) | ||||
CARD8-AS1 | CARD8-AS1 | LOC100505812 | CARD8 antisense RNA 1 | ||||
CARMN | CARMN | CARMEN | cardiac mesoderm enhancer-associated non-coding RNA | ||||
CASC11 | CASC11 | TCONSN/A00014535, LINC00990, CARLo-7 | cancer susceptibility candidate 11 (non-protein coding) | ||||
CASC15 | CASC15 | N/A | cancer susceptibility candidate 15 (non-protein coding) | ||||
CASC19 | CASC19 | CARLo-6 | cancer susceptibility candidate 19 (non-protein coding) | ||||
CASC2 | CASC2 | N/A | cancer susceptibility candidate 2 (non-protein coding) | ||||
CASC21 | CASC21 | CARLo-2 | cancer susceptibility candidate 21 (non-protein coding) | ||||
CASC22 | CASC22 | TCONSN/A00024290, LincRNA-ENST00000515084 | cancer susceptibility candidate 22 (non-protein coding) | ||||
CASC9 | CASC9 | LINC00981, ESCCAL-1 | cancer susceptibility candidate 9 (non-protein coding) | ||||
CBR3-AS1 | CBR3-AS1 | PlncRNA-1 | CBR3 antisense RNA 1 | ||||
CCDC18-AS1 | CCDC18-AS1 | ENST00000440778.1 | CCDC18 antisense RNA 1 | ||||
CCDC26 | CCDC26 | MGC27434, RAM | CCDC26 long non-coding RNA | ||||
CCEPR | CCEPR | CCHE1 | cervical carcinoma expressed PCNA regulatory lncRNA | ||||
CDKN1A-AS1 | CDKN1A-AS1 | p21NAT | CDKN1A antisense RNA 1 | ||||
CDR1-AS | CDR1-AS | CDR1NAT, ciRS-7, CDR1as | CDR1 antisense RNA | ||||
CDRT7 | CDRT7 | NCRNA00025, LINC00025 | CMT1A duplicated region transcript 7 (non-protein coding) | ||||
CDRT8 | CDRT8 | N/A | CMT1A duplicated region transcript 8 | ||||
CECR3 | CECR3 | N/A | cat eye syndrome chromosome region, candidate 3 (non-protein coding) | ||||
CECR5-AS1 | CECR5-AS1 | NCRNA00017 | CECR5 antisense RNA 1 | ||||
CECR7 | CECR7 | SAHL1 | cat eye syndrome chromosome region, candidate 7 (non-protein coding) | ||||
CECR9 | CECR9 | N/A | cat eye syndrome chromosome region, candidate 9 (non-protein coding) | ||||
CEP83-AS1 | CEP83-AS1 | N/A | CEP83 antisense RNA 1 (head to head) | ||||
CIRBP-AS1 | CIRBP-AS1 | MGC39338 | CIRBP antisense RNA 1 | ||||
CLRN1-AS1 | CLRN1-AS1 | UCRP | CLRN1 antisense RNA 1 | ||||
COPG2IT1 | COPG2IT1 | CIT1, NCRNA00170, COPG2AS | COPG2 imprinted transcript 1 (non-protein coding) | ||||
CPS1-IT1 | CPS1-IT1 | PRO0132, CPS1-IT | CPS1 intronic transcript 1 | ||||
CSNK1G2-AS1 | CSNK1G2-AS1 | MGC39696 | CSNK1G2 antisense RNA 1 | ||||
CSTF3-AS1 | CSTF3-AS1 | N/A | CSTF3 antisense RNA 1 (head to head) | ||||
CTBP1-AS | CTBP1-AS | PCAT10 | CTBP1 antisense RNA | ||||
CTBP1-AS2 | CTBP1-AS2 | MGC21675 | CTBP1 antisense RNA 2 (head to head) | ||||
CYP1B1-AS1 | CYP1B1-AS1 | MGC34824 | CYP1B1 antisense RNA 1 | ||||
CYP51A1-AS1 | CYP51A1-AS1 | ENST00000453068, LRRD1-AS1 | CYP51A1 antisense RNA 1 | ||||
DACOR1 | DACOR1 | TCONSN/A00023265 | DNMT1-associated colon cancer repressed lncRNA 1 | ||||
DANT1 | DANT1 | N/A | DXZ4 associated non-coding transcript 1, proximal | ||||
DANT2 | DANT2 | N/A | DXZ4 associated non-coding transcript 2, distal | ||||
DAOA-AS1 | DAOA-AS1 | G30 | DAOA antisense RNA 1 | ||||
DAPK1-IT1 | DAPK1-IT1 | N/A | DAPK1 intronic transcript 1 | ||||
DBH-AS1 | DBH-AS1 | BPR | DBH antisense RNA 1 | ||||
DGCR10 | DGCR10 | DGS-B | DiGeorge syndrome critical region gene 10 (non-protein coding) | ||||
DGCR11 | DGCR11 | DGS-D | DiGeorge syndrome critical region gene 11 (non-protein coding) | ||||
DGCR12 | DGCR12 | DGS-E | DiGeorge syndrome critical region gene 12 (non-protein coding) | ||||
DGCR5 | DGCR5 | NCRNA00037, LINC00037 | DiGeorge syndrome critical region gene 5 (non-protein coding) | ||||
DGCR9 | DGCR9 | DGS-A, POM121L5P | DiGeorge syndrome critical region gene 9 (non-protein coding) | ||||
DIAPH2-AS1 | DIAPH2-AS1 | N/A | DIAPH2 antisense RNA 1 | ||||
DISC1FP1 | DISC1FP1 | N/A | DISC1 fusion partner 1 (non-protein coding) | ||||
DLG2-AS1 | DLG2-AS1 | PSZA11q14, SZ-1 | DLG2 antisense RNA 1 | ||||
DLGAP1-AS3 | DLGAP1-AS3 | N/A | DLGAP1 antisense RNA 3 | ||||
DLX6-AS1 | DLX6-AS1 | FLJ34048, Evf-2 | DLX6 antisense RNA 1 | ||||
DNM3OS | DNM3OS | MIR199A2HG, DNM3-AS1 | DNM3 opposite strand/antisense RNA | ||||
DRAIC | DRAIC | N/A | downregulated RNA in cancer, inhibitor of cell invasion and migration | ||||
DSCR10 | DSCR10 | N/A | Down syndrome critical region 10 (non-protein coding) | ||||
DSCR9 | DSCR9 | NCRNA00038 | Down syndrome critical region 9 (non-protein coding) | ||||
DUBR | DUBR | N/A | DPPA2 upstream binding RNA | ||||
EGFR-AS1 | EGFR-AS1 | N/A | EGFR antisense RNA 1 | ||||
ELFN1-AS1 | ELFN1-AS1 | N/A | ELFN1 antisense RNA 1 | ||||
ENTPD3-AS1 | ENTPD3-AS1 | FLJ36665 | ENTPD3 antisense RNA 1 | ||||
EPB41L4A-AS1 | EPB41L4A-AS1 | TIGA1 | EPB41L4A antisense RNA 1 | ||||
EPB41L4A-AS2 | EPB41L4A-AS2 | FLJ11235 | EPB41L4A antisense RNA 2 (head to head) | ||||
ERC2-IT1 | ERC2-IT1 | Po42 | ERC2 intronic transcript 1 | ||||
ERICH1-AS1 | ERICH1-AS1 | N/A | ERICH1 antisense RNA 1 | ||||
EWSAT1 | EWSAT1 | FLJ33768 | Ewing sarcoma associated transcript 1 | ||||
EXOC3-AS1 | EXOC3-AS1 | N/A | EXOC3 antisense RNA 1 | ||||
EXTL3-AS1 | EXTL3-AS1 | N/A | EXTL3 antisense RNA 1 | ||||
F11-AS1 | F11-AS1 | N/A | F11 antisense RNA 1 | ||||
FAM138A | FAM138A | F379 | family with sequence similarity 138 member A | ||||
FAM138B | FAM138B | F379 | family with sequence similarity 138 member B | ||||
FAM138C | FAM138C | F379 | family with sequence similarity 138 member C | ||||
FAM138D | FAM138D | F379 | family with sequence similarity 138 member D | ||||
FAM138E | FAM138E | F379 | family with sequence similarity 138 member E | ||||
FAM138F | FAM138F | F379 | family with sequence similarity 138 member F | ||||
FAM13A-AS1 | FAM13A-AS1 | NCRNA00039 | FAM13A antisense RNA 1 | ||||
FAM201A | FAM201A | N/A | family with sequence similarity 201 member A | ||||
FAM215A | FAM215A | APR-2, LINC00530 | family with sequence similarity 215 member A (non-protein coding) | ||||
FAM222A-AS1 | FAM222A-AS1 | N/A | FAM222A antisense RNA 1 | ||||
FAM226A | FAM226A | MGC34827 | family with sequence similarity 226 member A (non-protein coding) | ||||
FAM226B | FAM226B | N/A | family with sequence similarity 226 member B (non-protein coding) | ||||
FAM27E3 | FAM27E3 | MGC42630 | family with sequence similarity 27 member E3 | ||||
FAM41AY1 | FAM41AY1 | N/A | family with sequence similarity 41 member A, Y-linked 1 | ||||
FAM41C | FAM41C | N/A | family with sequence similarity 41 member C | ||||
FAM66C | FAM66C | N/A | family with sequence similarity 66 member C | ||||
FAM74A3 | FAM74A3 | OTTHUMG00000067149 | family with sequence similarity 74 member A3 | ||||
FAM83H-AS1 | FAM83H-AS1 | onco-lncRNA-3 | FAM83H antisense RNA 1 (head to head) | ||||
FAM87A | FAM87A | N/A | family with sequence similarity 87 member A | ||||
FAS-AS1 | FAS-AS1 | SAF | FAS antisense RNA 1 | ||||
FGF10-AS1 | FGF10-AS1 | RP11-473L15.2 | FGF10 antisense RNA 1 | ||||
FLG-AS1 | FLG-AS1 | N/A | FLG antisense RNA 1 | ||||
FLVCR1-AS1 | FLVCR1-AS1 | LQK1 | FLVCR1 antisense RNA 1 (head to head) | ||||
FMR1-AS1 | FMR1-AS1 | ASFMR1, FMR4 | FMR1 antisense RNA 1 | ||||
FOXC2-AS1 | FOXC2-AS1 | ODRUL | FOXC2 antisense RNA 1 | ||||
FOXG1-AS1 | FOXG1-AS1 | FOXG1-AS | FOXG1 antisense RNA 1 (head to head) | ||||
FRGCA | FRGCA | LncRNA-AP001631.9 | FOXM1-regulated, gastric cancer associated | ||||
GABPB1-AS1 | GABPB1-AS1 | N/A | GABPB1 antisense RNA 1 | ||||
GACAT1 | ENST00000441383.1 | LINC00876, AC096655.1-002 | gastric cancer associated transcript 1 (non-protein coding) | ||||
GACAT2 | ENST00000579368.1 | HMlincRNA717 | gastric cancer associated transcript 2 (non-protein coding) | ||||
GACAT3 | ENST00000426539.1 | lncRNA-AC130710 | gastric cancer associated transcript 3 (non-protein coding) | ||||
GAPLINC | GAPLINC | TCONSN/A00026238 | gastric adenocarcinoma associated, positive CD44 regulator, long intergenic non-coding RNA | ||||
GAS1RR | GAS1RR | LncRNA-Hh | GAS1 adjacent regulatory RNA | ||||
GAS6-AS1 | GAS6-AS1 | N/A | GAS6 antisense RNA 1 | ||||
GAS8-AS1 | GAS8-AS1 | N/A | GAS8 antisense RNA 1 | ||||
GATA3-AS1 | GATA3-AS1 | N/A | GATA3 antisense RNA 1 | ||||
GATA6-AS1 | GATA6-AS1 | locus5689 | GATA6 antisense RNA 1 (head to head) | ||||
GDNF-AS1 | GDNF-AS1 | GDNFOS | GDNF antisense RNA 1 (head to head) | ||||
GLIDR | GLIDR | MGC21881, TCONSN/A00015562 | glioblastoma down-regulated RNA | ||||
GLIS3-AS1 | GLIS3-AS1 | MGC16153 | GLIS3 antisense RNA 1 | ||||
GNG12-AS1 | GNG12-AS1 | N/A | GNG12 antisense RNA 1 | ||||
GTSCR1 | GTSCR1 | N/A | Gilles de la Tourette syndrome chromosome region, candidate 1 (non-protein coding) | ||||
H1FX-AS1 | H1FX-AS1 | FLJ34151 | H1FX antisense RNA 1 | ||||
HAND2-AS1 | HAND2-AS1 | DEIN, NBLA00301, FLJ11539 | HAND2 antisense RNA 1 (head to head) | ||||
HAS2-AS1 | HAS2-AS1 | HASNT, NCRNA00077 | HAS2 antisense RNA 1 | ||||
HCCAT5 | HCCAT5 | HTA, FJ222407 | hepatocellular carcinoma associated transcript 5 (non-protein coding) | ||||
HCG27 | HCG27 | bPG299F13.9, bCX101P6.9, bQB115I13.2, FLJ40123 | HLA complex group 27 (non-protein coding) | ||||
HCG4 | HCG4 | HCGIV-10, HCGIV.9 | HLA complex group 4 (non-protein coding) | ||||
HCG4B | HCG4B | HCGIV-6, HCGIV.5, HCGIV-06, bCX67J3.3, Em:AB023056.16, bPG309N1.1, bQB90C11.3 | HLA complex group 4B (non-protein coding) | ||||
HCG9 | HCG9 | PERB11, HCGIX, HCGIX4, HCGIX-4 | HLA complex group 9 (non-protein coding) | ||||
HCP5 | HCP5 | D6S2650E, P5-1 | HLA complex P5 (non-protein coding) | ||||
HELLPAR | HELLPAR | LINC-HELLP | HELLP associated long non-coding RNA | ||||
HEXA-AS1 | HEXA-AS1 | FLJ13315 | HEXA antisense RNA 1 | ||||
HIF1A-AS1 | HIF1A-AS1 | 5'aHIF-1A | HIF1A antisense RNA 1 | ||||
HIF1A-AS2 | HIF1A-AS2 | 3'aHIF-1A, aHIF | HIF1A antisense RNA 2 | ||||
HNF1A-AS1 | HNF1A-AS1 | FLJ38690 | HNF1A antisense RNA 1 | ||||
HNF4A-AS1 | HNF4A-AS1 | uc002xlx | HNF4A antisense RNA 1 | ||||
HORMAD2-AS1 | HORMAD2-AS1 | MTMR3-AS1, NONHSAG033653 | HORMAD2 antisense RNA 1 | ||||
HPVC1 | HPVC1 | PE5L, HPV18E5L | human papillomavirus (type 18) E5 central sequence-like 1 | ||||
HTT-AS | HTT-AS | HTTAS | HTT antisense RNA (head to head) | ||||
HYMAI | HYMAI | NCRNA00020 | hydatidiform mole associated and imprinted (non-protein coding) | ||||
IDI2-AS1 | IDI2-AS1 | HT009, Em:AC022536.4 | IDI2 antisense RNA 1 | ||||
IGF2-AS | IGF2-AS | PEG8, IGF2-AS1 | IGF2 antisense RNA | ||||
ILF3-AS1 | ILF3-AS1 | N/A | ILF3 antisense RNA 1 (head to head) | ||||
INE1 | INE1 | NCRNA00010 | inactivation escape 1 (non-protein coding) | ||||
INE2 | INE2 | NCRNA00011 | inactivation escape 2 (non-protein coding) | ||||
IRAIN | IRAIN | IGF1R-AS | IGF1R antisense imprinted non-protein coding RNA | ||||
JMJD1C-AS1 | JMJD1C-AS1 | N/A | JMJD1C antisense RNA 1 | ||||
KCNK15-AS1 | KCNK15-AS1 | RP11-445H22.4 | KCNK15 antisense RNA 1 (head to head) | ||||
KCNMB2-AS1 | KCNMB2-AS1 | RP11-385J1.2 | KCNMB2 antisense RNA 1 | ||||
KCNQ1DN | KCNQ1DN | BWRT, HSA404617 | KCNQ1 downstream neighbor (non-protein coding) | ||||
KIAA1614-AS1 | KIAA1614-AS1 | RP11-46A10.4 | KIAA1614 antisense RNA 1 | ||||
KIF25-AS1 | KIF25-AS1 | HGC6.1.1 | KIF25 antisense RNA 1 | ||||
LAMP5-AS1 | LAMP5-AS1 | N/A | LAMP5 antisense RNA 1 | ||||
LBX2-AS1 | LBX2-AS1 | N/A | LBX2 antisense RNA 1 | ||||
LCAL1 | LCAL1 | onco-lncRNA-27 | lung cancer associated lncRNA 1 | ||||
LHX5-AS1 | LHX5-AS1 | locus4010 | LHX5 antisense RNA 1 (head to head) | ||||
LIFR-AS1 | LIFR-AS1 | N/A | LIFR antisense RNA 1 | ||||
LINC00029 | LINC00029 | bA305P22.4 | long intergenic non-protein coding RNA 29 | ||||
LINC00052 | LINC00052 | FLJ31461 | long intergenic non-protein coding RNA 52 | ||||
LINC00094 | LINC00094 | FLJ35348, bA374P20.3 | long intergenic non-protein coding RNA 94 | ||||
LINC00114 | LINC00114 | N/A | long intergenic non-protein coding RNA 114 | ||||
LINC00115 | LINC00115 | FLJ22639 | long intergenic non-protein coding RNA 115 | ||||
LINC00152 | LINC00152 | MGC4677 | long intergenic non-protein coding RNA 152 | ||||
LINC00160 | LINC00160 | N/A | long intergenic non-protein coding RNA 160 | ||||
LINC00161 | LINC00161 | N/A | long intergenic non-protein coding RNA 161 | ||||
LINC00165 | LINC00165 | NLC1-B | long intergenic non-protein coding RNA 165 | ||||
LINC00189 | LINC00189 | N/A | long intergenic non-protein coding RNA 189 | ||||
LINC00205 | LINC00205 | N/A | long intergenic non-protein coding RNA 205 | ||||
LINC00235 | LINC00235 | N/A | long intergenic non-protein coding RNA 235 | ||||
LINC00237 | LINC00237 | N/A | long intergenic non-protein coding RNA 237 | ||||
LINC00244 | LINC00244 | N/A | long intergenic non-protein coding RNA 244 | ||||
LINC00261 | LINC00261 | bA216C10.1, HCCDR1, TCONSN/A00027846, ALIEN, DEANR1, onco-lncRNA-17 | long intergenic non-protein coding RNA 261 | ||||
LINC00265 | LINC00265 | NCRNA00265-1 | long intergenic non-protein coding RNA 265 | ||||
LINC00272 | LINC00272 | RP1-223H12.3 | long intergenic non-protein coding RNA 272 | ||||
LINC00293 | LINC00293 | BEYLA | long intergenic non-protein coding RNA 293 | ||||
LINC00294 | LINC00294 | N/A | long intergenic non-protein coding RNA 294 | ||||
LINC00299 | LINC00299 | FLJ45673 | long intergenic non-protein coding RNA 299 | ||||
LINC00301 | LINC00301 | MGC39681 | long intergenic non-protein coding RNA 301 | ||||
LINC00302 | LINC00302 | XP33 | long intergenic non-protein coding RNA 302 | ||||
LINC00305 | LINC00305 | MGC39571, HsT1235 | long intergenic non-protein coding RNA 305 | ||||
LINC00307 | LINC00307 | D21S2091E | long intergenic non-protein coding RNA 307 | ||||
LINC00308 | LINC00308 | PRED16 | long intergenic non-protein coding RNA 308 | ||||
LINC00310 | LINC00310 | N/A | long intergenic non-protein coding RNA 310 | ||||
LINC00311 | LINC00311 | MGC22001 | long intergenic non-protein coding RNA 311 | ||||
LINC00313 | LINC00313 | N/A | long intergenic non-protein coding RNA 313 | ||||
LINC00314 | LINC00314 | N/A | long intergenic non-protein coding RNA 314 | ||||
LINC00315 | LINC00315 | N/A | long intergenic non-protein coding RNA 315 | ||||
LINC00320 | LINC00320 | PRED14, FLJ37539 | long intergenic non-protein coding RNA 320 | ||||
LINC00322 | LINC00322 | FLJ16545 | long intergenic non-protein coding RNA 322 | ||||
LINC00323 | LINC00323 | PRED42, FLJ37173 | long intergenic non-protein coding RNA 323 | ||||
LINC00324 | LINC00324 | FLJ34790, MGC104931 | long intergenic non-protein coding RNA 324 | ||||
LINC00334 | LINC00334 | N/A | long intergenic non-protein coding RNA 334 | ||||
LINC00337 | LINC00337 | MGC40168 | long intergenic non-protein coding RNA 337 | ||||
LINC00339 | LINC00339 | HSPC157 | long intergenic non-protein coding RNA 339 | ||||
LINC00342 | LINC00342 | N/A | long intergenic non-protein coding RNA 342 | ||||
LINC00346 | LINC00346 | N/A | long intergenic non-protein coding RNA 346 | ||||
LINC00347 | LINC00347 | N/A | long intergenic non-protein coding RNA 347 | ||||
LINC00426 | LINC00426 | N/A | long intergenic non-protein coding RNA 426 | ||||
LINC00441 | LINC00441 | ncRNA-RB1 | long intergenic non-protein coding RNA 441 | ||||
LINC00461 | LINC00461 | EyeLinc1, Visc-1a, Visc-1b, Visc-2, LOC645323 | long intergenic non-protein coding RNA 461 | ||||
LINC00466 | LINC00466 | N/A | long intergenic non-protein coding RNA 466 | ||||
LINC00467 | LINC00467 | MGC14801 | long intergenic non-protein coding RNA 467 | ||||
LINC00470 | LINC00470 | N/A | long intergenic non-protein coding RNA 470 | ||||
LINC00471 | LINC00471 | MGC43122 | long intergenic non-protein coding RNA 471 | ||||
LINC00472 | LINC00472 | dJ288M22.3, FLJ13189 | long intergenic non-protein coding RNA 472 | ||||
LINC00473 | LINC00473 | bA142J11.1 | long intergenic non-protein coding RNA 473 | ||||
LINC00477 | LINC00477 | FLJ32894, FAM191B | long intergenic non-protein coding RNA 477 | ||||
LINC00491 | LINC00491 | BC008363 | long intergenic non-protein coding RNA 491 | ||||
LINC00493 | LINC00493 | LOC388789 | long intergenic non-protein coding RNA 493 | ||||
LINC00494 | LINC00494 | N/A | long intergenic non-protein coding RNA 494 | ||||
LINC00507 | LINC00507 | N/A | long intergenic non-protein coding RNA 507 | ||||
LINC00511 | LINC00511 | onco-lncRNA-12 | long intergenic non-protein coding RNA 511 | ||||
LINC00518 | LINC00518 | MGC40222 | long intergenic non-protein coding RNA 518 | ||||
LINC00526 | LINC00526 | MGC17515, HsT959 | long intergenic non-protein coding RNA 526 | ||||
LINC00528 | LINC00528 | FLJ40542 | long intergenic non-protein coding RNA 528 | ||||
LINC00529 | LINC00529 | N/A | long intergenic non-protein coding RNA 529 | ||||
LINC00536 | LINC00536 | N/A | long intergenic non-protein coding RNA 536 | ||||
LINC00538 | LINC00538 | Yiya, PROX1UT | long intergenic non-protein coding RNA 538 | ||||
LINC00575 | LINC00575 | N/A | long intergenic non-protein coding RNA 575 | ||||
LINC00588 | LINC00588 | DKFZP434F122 | long intergenic non-protein coding RNA 588 | ||||
LINC00593 | LINC00593 | MGC42951 | long intergenic non-protein coding RNA 593 | ||||
LINC00598 | LINC00598 | TTL | long intergenic non-protein coding RNA 598 | ||||
LINC00608 | LINC00608 | N/A | long intergenic non-protein coding RNA 608 | ||||
LINC00612 | LINC00612 | MGC40170, FLJ41814 | long intergenic non-protein coding RNA 612 | ||||
LINC00620 | LINC00620 | N/A | long intergenic non-protein coding RNA 620 | ||||
LINC00623 | LINC00623 | N/A | long intergenic non-protein coding RNA 623 | ||||
LINC00628 | LINC00628 | N/A | long intergenic non-protein coding RNA 628 | ||||
LINC00632 | LINC00632 | N/A | long intergenic non-protein coding RNA 632 | ||||
LINC00634 | LINC00634 | N/A | long intergenic non-protein coding RNA 634 | ||||
LINC00635 | LINC00635 | N/A | long intergenic non-protein coding RNA 635 | ||||
LINC00636 | LINC00636 | N/A | long intergenic non-protein coding RNA 636 | ||||
LINC00638 | LINC00638 | MGC23270 | long intergenic non-protein coding RNA 638 | ||||
LINC00649 | LINC00649 | TCONSN/A00028768 | long intergenic non-protein coding RNA 649 | ||||
LINC00652 | LINC00652 | HSPC072 | long intergenic non-protein coding RNA 652 | ||||
LINC00661 | LINC00661 | N/A | long intergenic non-protein coding RNA 661 | ||||
LINC00662 | LINC00662 | N/A | long intergenic non-protein coding RNA 662 | ||||
LINC00663 | LINC00663 | MGC39821 | long intergenic non-protein coding RNA 663 | ||||
LINC00667 | LINC00667 | N/A | long intergenic non-protein coding RNA 667 | ||||
LINC00668 | LINC00668 | N/A | long intergenic non-protein coding RNA 668 | ||||
LINC00673 | LINC00673 | HI-LNC75 | long intergenic non-protein coding RNA 673 | ||||
LINC00675 | LINC00675 | N/A | long intergenic non-protein coding RNA 675 | ||||
LINC00682 | LINC00682 | N/A | long intergenic non-protein coding RNA 682 | ||||
LINC00685 | LINC00685 | OTTHUMT00000055574 | long intergenic non-protein coding RNA 685 | ||||
LINC00689 | LINC00689 | N/A | long intergenic non-protein coding RNA 689 | ||||
LINC00692 | LINC00692 | N/A | long intergenic non-protein coding RNA 692 | ||||
LINC00704 | LINC00704 | N/A | long intergenic non-protein coding RNA 704 | ||||
LINC00705 | LINC00705 | N/A | long intergenic non-protein coding RNA 705 | ||||
LINC00839 | LINC00839 | N/A | long intergenic non-protein coding RNA 839 | ||||
LINC00852 | LINC00852 | NAG73, GHRL-AS2 | long intergenic non-protein coding RNA 852 | ||||
LINC00854 | LINC00854 | N/A | long intergenic non-protein coding RNA 854 | ||||
LINC00857 | LINC00857 | N/A | long intergenic non-protein coding RNA 857 | ||||
LINC00868 | LINC00868 | N/A | long intergenic non-protein coding RNA 868 | ||||
LINC00869 | LINC00869 | KIAA0493 | long intergenic non-protein coding RNA 869 | ||||
LINC00880 | LINC00880 | N/A | long intergenic non-protein coding RNA 880 | ||||
LINC00882 | LINC00882 | N/A | long intergenic non-protein coding RNA 882 | ||||
LINC00887 | LINC00887 | linc-ATP13A4-8 | long intergenic non-protein coding RNA 887 | ||||
LINC00893 | LINC00893 | N/A | long intergenic non-protein coding RNA 893 | ||||
LINC00901 | LINC00901 | TCONSN/A00005428, BC040587 | long intergenic non-protein coding RNA 901 | ||||
LINC00917 | LINC00917 | N/A | long intergenic non-protein coding RNA 917 | ||||
LINC00936 | LINC00936 | N/A | long intergenic non-protein coding RNA 936 | ||||
LINC00942 | LINC00942 | N/A | long intergenic non-protein coding RNA 942 | ||||
LINC00950 | LINC00950 | FP588 | long intergenic non-protein coding RNA 950 | ||||
LINC00951 | LINC00951 | lincRNA-uc003opf.1, FLJ41649 | long intergenic non-protein coding RNA 951 | ||||
LINC00961 | LINC00961 | N/A | long intergenic non-protein coding RNA 961 | ||||
LINC00963 | LINC00963 | N/A | long intergenic non-protein coding RNA 963 | ||||
LINC00964 | LINC00964 | N/A | long intergenic non-protein coding RNA 964 | ||||
LINC00970 | LINC00970 | N/A | long intergenic non-protein coding RNA 970 | ||||
LINC00974 | LINC00974 | N/A | long intergenic non-protein coding RNA 974 | ||||
LINC00977 | LINC00977 | N/A | long intergenic non-protein coding RNA 977 | ||||
LINC00982 | LINC00982 | FLJ42875 | long intergenic non-protein coding RNA 982 | ||||
LINC00993 | LINC00993 | N/A | long intergenic non-protein coding RNA 993 | ||||
LINC00994 | LINC00994 | N/A | long intergenic non-protein coding RNA 994 | ||||
LINC00996 | LINC00996 | N/A | long intergenic non-protein coding RNA 996 | ||||
LINC01016 | LINC01016 | N/A | long intergenic non-protein coding RNA 1016 | ||||
LINC01018 | LINC01018 | N/A | long intergenic non-protein coding RNA 1018 | ||||
LINC01019 | LINC01019 | N/A | long intergenic non-protein coding RNA 1019 | ||||
LINC01020 | LINC01020 | N/A | long intergenic non-protein coding RNA 1020 | ||||
LINC01021 | LINC01021 | N/A | long intergenic non-protein coding RNA 1021 | ||||
LINC01024 | LINC01024 | MA-linc1 | long intergenic non-protein coding RNA 1024 | ||||
LINC01029 | LINC01029 | N/A | long intergenic non-protein coding RNA 1029 | ||||
LINC01080 | LINC01080 | TCONSN/A00021856 | long intergenic non-protein coding RNA 1080 | ||||
LINC01081 | LINC01081 | TCONSN/A00024764 | long intergenic non-protein coding RNA 1081 | ||||
LINC01082 | LINC01082 | TCONSN/A00024492 | long intergenic non-protein coding RNA 1082 | ||||
LINC01089 | LINC01089 | N/A | long intergenic non-protein coding RNA 1089 | ||||
LINC01090 | LINC01090 | N/A | long intergenic non-protein coding RNA 1090 | ||||
LINC01091 | LINC01091 | N/A | long intergenic non-protein coding RNA 1091 | ||||
LINC01096 | LINC01096 | N/A | long intergenic non-protein coding RNA 1096 | ||||
LINC01105 | LINC01105 | FLJ30594, LOC150622 | long intergenic non-protein coding RNA 1105 | ||||
LINC01108 | LINC01108 | LncRNA-ES1 | long intergenic non-protein coding RNA 1108 | ||||
LINC01122 | LINC01122 | FLJ30838 | long intergenic non-protein coding RNA 1122 | ||||
LINC01133 | LINC01133 | N/A | long intergenic non-protein coding RNA 1133 | ||||
LINC01139 | LINC01139 | N/A | long intergenic non-protein coding RNA 1139 | ||||
LINC01140 | LINC01140 | FLJ41676 | long intergenic non-protein coding RNA 1140 | ||||
LINC01150 | LINC01150 | 2G7, TCONSN/A00019134 | long intergenic non-protein coding RNA 1150 | ||||
LINC01152 | LINC01152 | TCONSN/A00025128, CMPD | long intergenic non-protein coding RNA 1152 | ||||
LINC01154 | LINC01154 | N/A | long intergenic non-protein coding RNA 1154 | ||||
LINC01157 | LINC01157 | TCONSN/A00010378, linc-Enc1 | long intergenic non-protein coding RNA 1157 | ||||
LINC01158 | LINC01158 | linc-Brn1a | long intergenic non-protein coding RNA 1158 | ||||
LINC01159 | LINC01159 | linc-Brn1b | long intergenic non-protein coding RNA 1159 | ||||
LINC01184 | LINC01184 | FLJ33630 | long intergenic non-protein coding RNA 1184 | ||||
LINC01185 | LINC01185 | FLJ16341 | long intergenic non-protein coding RNA 1185 | ||||
LINC01192 | LINC01192 | N/A | long intergenic non-protein coding RNA 1192 | ||||
LINC01193 | LINC01193 | LOC348120 | long intergenic non-protein coding RNA 1193 | ||||
LINC01194 | LINC01194 | TAG | long intergenic non-protein coding RNA 1194 | ||||
LINC01202 | LINC01202 | N/A | long intergenic non-protein coding RNA 1202 | ||||
LINC01207 | LINC01207 | N/A | long intergenic non-protein coding RNA 1207 | ||||
LINC01225 | LINC01225 | N/A | long intergenic non-protein coding RNA 1225 | ||||
LINC01228 | LINC01228 | lincRNA-DYNLRB2-2 | long intergenic non-protein coding RNA 1228 | ||||
LINC01230 | LINC01230 | linc-DMRT2, lnc-DRMT2, TCONSN/A00015639 | long intergenic non-protein coding RNA 1230 | ||||
LINC01232 | LINC01232 | FLJ41590, TCONSN/A00021520 | long intergenic non-protein coding RNA 1232 | ||||
LINC01233 | LINC01233 | XLOCN/A013014 | long intergenic non-protein coding RNA 1233 | ||||
LINC01234 | LINC01234 | onco-lncRNA-32 | long intergenic non-protein coding RNA 1234 | ||||
LINC01252 | LINC01252 | N/A | long intergenic non-protein coding RNA 1252 | ||||
LINC01262 | LINC01262 | TCONSN/Al2N/A00021807, RP11-462G22.1 | long intergenic non-protein coding RNA 1262 | ||||
LINC01264 | LINC01264 | RP11-124O11.2 | long intergenic non-protein coding RNA 1264 | ||||
LINC01268 | LINC01268 | LOC285758 | long intergenic non-protein coding RNA 1268 | ||||
LINC01296 | LINC01296 | FLJ39632 | long intergenic non-protein coding RNA 1296 | ||||
LINC01312 | LINC01312 | MGC34034 | long intergenic non-protein coding RNA 1312 | ||||
LINC01317 | LINC01317 | N/A | long intergenic non-protein coding RNA 1317 | ||||
LINC01370 | LINC01370 | HI-LNC25 | long intergenic non-protein coding RNA 1370 | ||||
LINC01374 | LINC01374 | TCONSN/A00018278 | long intergenic non-protein coding RNA 1374 | ||||
LINC01405 | LINC01405 | N/A | long intergenic non-protein coding RNA 1405 | ||||
LINC01411 | LINC01411 | RP11-267A15.1 | long intergenic non-protein coding RNA 1411 | ||||
LINC01420 | LINC01420 | N/A | long intergenic non-protein coding RNA 1420 | ||||
LINC01433 | LINC01433 | LOC728228 | long intergenic non-protein coding RNA 1433 | ||||
LINC01435 | LINC01435 | RP11-215N21.1, TCONSN/A00018040 | long intergenic non-protein coding RNA 1435 | ||||
LINC01436 | LINC01436 | AP000688.8 | long intergenic non-protein coding RNA 1436 | ||||
LINC01468 | LINC01468 | lnc-MBL2-4 | long intergenic non-protein coding RNA 1468 | ||||
LINC01478 | LINC01478 | N/A | long intergenic non-protein coding RNA 1478 | ||||
LINC01501 | LINC01501 | N/A | long intergenic non-protein coding RNA 1501 | ||||
LINC01503 | LINC01503 | lnc-PPP2R4-5 | long intergenic non-protein coding RNA 1503 | ||||
LINC01507 | LINC01507 | XLOCN/A000303 | long intergenic non-protein coding RNA 1507 | ||||
LINC01511 | LINC01511 | RP11-325I22.2 | long intergenic non-protein coding RNA 1511 | ||||
LINC01512 | LINC01512 | LOC100132354, TCONSN/A00011120, HI-LNC77 | long intergenic non-protein coding RNA 1512 | ||||
LINC01513 | LINC01513 | RP11-1C1.7, TCONSN/A00009352 | long intergenic non-protein coding RNA 1513 | ||||
LINC01525 | LINC01525 | lnc-MAN1A2-1 | long intergenic non-protein coding RNA 1525 | ||||
LINC01526 | LINC01526 | Lnc-FAM46A-1 | long intergenic non-protein coding RNA 1526 | ||||
LINC01527 | LINC01527 | lnc-SPRR2D-1 | long intergenic non-protein coding RNA 1527 | ||||
LINC01537 | LINC01537 | RP11-169D4.1-001 | long intergenic non-protein coding RNA 1537 | ||||
LINC01547 | LINC01547 | N/A | long intergenic non-protein coding RNA 1547 | ||||
LINC01553 | LINC01553 | AC023904.2 | long intergenic non-protein coding RNA 1553 | ||||
LINC01558 | LINC01558 | HGC6.2, dJ431P23.4 | long intergenic non-protein coding RNA 1558 | ||||
LINC01559 | LINC01559 | FLJ33810 | long intergenic non-protein coding RNA 1559 | ||||
LINC01560 | LINC01560 | N/A | long intergenic non-protein coding RNA 1560 | ||||
LINC01562 | LINC01562 | RP11-296A18.3 | long intergenic non-protein coding RNA 1562 | ||||
LINC01564 | LINC01564 | TCONSN/A00011314 | long intergenic non-protein coding RNA 1564 | ||||
LINC01565 | LINC01565 | GR6 | long intergenic non-protein coding RNA 1565 | ||||
LINC01574 | LINC01574 | HI-LNC12, TCONSN/A00009551 | long intergenic non-protein coding RNA 1574 | ||||
LINC01587 | LINC01587 | aC1 | long intergenic non-protein coding RNA 1587 | ||||
LINC01589 | LINC01589 | CTA-941F9.9, TCONSN/A00029353 | long intergenic non-protein coding RNA 1589 | ||||
LINC01591 | LINC01591 | N/A | long intergenic non-protein coding RNA 1591 | ||||
LINC01602 | LINC01602 | T1560 | long intergenic non-protein coding RNA 1602 | ||||
LINC01611 | LINC01611 | RP1-90L14.1, TCONSN/Al2N/A00025430 | long intergenic non-protein coding RNA 1611 | ||||
LINC01612 | LINC01612 | RP11-789C1.1, TCONSN/A00008319 | long intergenic non-protein coding RNA 1612 | ||||
LINC01613 | LINC01613 | n341773 | long intergenic non-protein coding RNA 1613 | ||||
LINC01614 | LINC01614 | LCAL4, TCONSN/A00003105 | long intergenic non-protein coding RNA 1614 | ||||
LINC01616 | LINC01616 | n341006 | long intergenic non-protein coding RNA 1616 | ||||
LINC01617 | LINC01617 | XLOCN/A006844 | long intergenic non-protein coding RNA 1617 | ||||
LINC01618 | LINC01618 | LOC152578 | long intergenic non-protein coding RNA 1618 | ||||
LINC01622 | LINC01622 | TCONSN/A00011202 | long intergenic non-protein coding RNA 1622 | ||||
LINC01627 | LINC01627 | RP11-397D12.4 | long intergenic non-protein coding RNA 1627 | ||||
LINC01628 | LINC01628 | AC007403.1 | long intergenic non-protein coding RNA 1628 | ||||
LINC01629 | LINC01629 | linc-KIAA1737-2 | long intergenic non-protein coding RNA 1629 | ||||
LINCMD1 | LINCMD1 | N/A | long intergenic non-protein coding RNA, muscle differentiation 1 | ||||
LINGO1-AS1 | LINGO1-AS1 | N/A | LINGO1 antisense RNA 1 | ||||
LMCD1-AS1 | LMCD1-AS1 | N/A | LMCD1 antisense RNA 1 (head to head) | ||||
LOH12CR2 | LOH12CR2 | LOH2CR12 | loss of heterozygosity, 12, chromosomal region 2 (non-protein coding) | ||||
LOXL1-AS1 | LOXL1-AS1 | N/A | LOXL1 antisense RNA 1 | ||||
LPP-AS2 | LPP-AS2 | N/A | LPP antisense RNA 2 | ||||
LRP1-AS | LRP1-AS | N/A | LRP1 antisense RNA | ||||
LRRC75A-AS1 | LRRC75A-AS1 | MGC40157 | LRRC75A antisense RNA 1 | ||||
LUADT1 | LUADT1 | N/A | lung adenocarcinoma associated transcript 1 | ||||
LUNAR1 | LUNAR1 | N/A | leukemia-associated non-coding IGF1R activator RNA 1 | ||||
MAFA-AS1 | MAFA-AS1 | RP11-909N17.3, TCONSN/A00014882 | MAFA antisense RNA 1 | ||||
MAFG-AS1 | MAFG-AS1 | N/A | MAFG antisense RNA 1 (head to head) | ||||
MAFTRR | MAFTRR | linc-MAF-4 | MAF transcriptional regulator RNA | ||||
MAGEA8-AS1 | MAGEA8-AS1 | RP5-869M20.2 | MAGEA8 antisense RNA 1 (head to head) | ||||
MAPKAPK5-AS1 | MAPKAPK5-AS1 | FLJ39616 | MAPKAPK5 antisense RNA 1 | ||||
MCM3AP-AS1 | MCM3AP-AS1 | FLJ10508, NCRNA00031 | MCM3AP antisense RNA 1 | ||||
MDC1-AS1 | MDC1-AS1 | MDC1-AS | MDC1 antisense RNA 1 | ||||
MEF2C-AS1 | MEF2C-AS1 | N/A | MEF2C antisense RNA 1 | ||||
MEG9 | ENST00000553584.1,[[ | LINC00584 | maternally expressed 9 (non-protein coding) | ||||
MESTIT1 | MESTIT1 | NCRNA00040, MEST-AS1 | MEST intronic transcript 1, antisense RNA | ||||
MGAT3-AS1 | MGAT3-AS1 | TapSAKI | MGAT3 antisense RNA 1 | ||||
MHRT | MHRT | Myheart | myosin heavy chain-associated RNA transcript | ||||
MIF-AS1 | MIF-AS1 | LOC284889 | MIF antisense RNA 1 | ||||
MIMT1 | MIMT1 | MIM1, NCRNA00067, LINC00067 | MER1 repeat containing imprinted transcript 1 (non-protein coding) | ||||
MINCR | ENST00000517411.1 | TCONSN/A00015189 | MYC-induced long noncoding RNA | ||||
MIR137HG | MIR137HG | N/A | MIR137 host gene | ||||
MIR17HG | MIR17HG | FLJ14178, MIRH1, MIHG1, NCRNA00048, miR-17-92, LINC00048 | miR-17-92a-1 cluster host gene | ||||
MIR181A2HG | MIR181A2HG | N/A | MIR181A2 host gene | ||||
MIR210HG | MIR210HG | N/A | MIR210 host gene | ||||
MIR34AHG | MIR34AHG | N/A | MIR34A host gene | ||||
MIR4435-2HG | MIR4435-2HG | LINC00978, AGD2, AK001796 | MIR4435-2 host gene | ||||
MIR600HG | MIR600HG | GL012, FLJ22161 | MIR600 host gene | ||||
MIR663AHG | MIR663AHG | RP3-410C9.1 | MIR663A host gene | ||||
MIR7-3HG | MIR7-3HG | PGSF1, PGSF1a, PGSF1b, Huh7, uc002mbe.2 | MIR7-3 host gene | ||||
MIRLET7BHG | MIRLET7BHG | linc-Ppara | MIRLET7B host gene | ||||
MIRLET7DHG | MIRLET7DHG | N/A | MIRLET7D host gene | ||||
MKRN3-AS1 | MKRN3-AS1 | FNZ127, NCRNA00009, ZNF127-AS | MKRN3 antisense RNA 1 | ||||
MLK7-AS1 | MLK7-AS1 | N/A | MLK7 antisense RNA 1 | ||||
MLLT4-AS1 | MLLT4-AS1 | HGC6.4, dJ431P23.3 | MLLT4 antisense RNA 1 (head to head) | ||||
MORF4L2-AS1 | MORF4L2-AS1 | N/A | MORF4L2 antisense RNA 1 | ||||
MT-LIPCAR | MT-LIPCAR | uc022bqs.1, LIPCAR | mitochondrially encoded long non-coding cardiac associated RNA | ||||
MYCNOS | MYCNOS | NCYM, N-CYM, MYCN-AS1 | MYCN opposite strand | ||||
N4BP2L2-IT2 | N4BP2L2-IT2 | CG030 | N4BPL2 intronic transcript 2 | ||||
NALT1 | NALT1 | TCONSN/Al2N/A00029132 | NOTCH1 associated lncRNA in T-cell acute lymphoblastic leukemia 1 | ||||
NBAT1 | NBAT1 | NBAT-1 | neuroblastoma associated transcript 1 | ||||
NBR2 | NBR2 | NCRNA00192 | neighbor of BRCA1 gene 2 (non-protein coding) | ||||
NCBP2-AS2 | NCBP2-AS2 | N/A | NCBP2 antisense RNA 2 (head to head) | ||||
NCOA7-AS1 | NCOA7-AS1 | N/A | NCOA7 antisense RNA 1 | ||||
NCRUPAR | NCRUPAR | ncR-uPAR, ncRuPAR, NCRNA00193 | non-protein coding RNA, upstream of F2R/PAR1 | ||||
NFIA-AS1 | NFIA-AS1 | RP5-833A20.1 | NFIA antisense RNA 1 | ||||
NIPBL-AS1 | NIPBL-AS1 | NIPBL-AS | NIPBL antisense RNA 1 (head to head) | ||||
NKILA | NKILA | N/A | NF-kappaB interacting long non-coding RNA | ||||
NKX2-2-AS1 | NKX2-2-AS1 | NKX2-2AS | NKX2-2 antisense RNA 1 | ||||
NOP14-AS1 | NOP14-AS1 | RES4-24 | NOP14 antisense RNA 1 | ||||
NORAD | NORAD | N/A | non-coding RNA activated by DNA damage | ||||
NPHP3-AS1 | NPHP3-AS1 | N/A | NPHP3 antisense RNA 1 | ||||
NPPA-AS1 | NPPA-AS1 | N/A | NPPA antisense RNA 1 | ||||
NPSR1-AS1 | NPSR1-AS1 | AAA1, IMAGE:4827585 | NPSR1 antisense RNA 1 | ||||
NPTN-IT1 | NPTN-IT1 | lncRNA-LET | NPTN intronic transcript 1 | ||||
NR2F1-AS1 | NR2F1-AS1 | FLJ42709 | NR2F1 antisense RNA 1 | ||||
NRAV | NRAV | N/A | negative regulator of antiviral response (non-protein coding) | ||||
OLMALINC | OLMALINC | bA34D15.5, FLJ12974, HI-LNC80 | oligodendrocyte maturation-associated long intergenic non-coding RNA | ||||
PANCR | PANCR | N/A | PITX2 adjacent non-coding RNA | ||||
PAPPA-AS1 | PAPPA-AS1 | PAPPA-AS, DIPAS, TAF4B, TAF2C2, TAFII105, NCRNA00156 | PAPPA antisense RNA 1 | ||||
PAPPA-AS2 | PAPPA-AS2 | AGU1 | PAPPA antisense RNA 2 | ||||
PARTICL | PARTICL | PARTICLE | promoter of MAT2A antisense radiation-induced circulating long non-coding RNA | ||||
PAXIP1-AS1 | PAXIP1-AS1 | N/A | PAXIP1 antisense RNA 1 (head to head) | ||||
PCAT14 | PCAT14 | N/A | prostate cancer associated transcript 14 (non-protein coding) | ||||
PCAT18 | PCAT18 | LINC01092 | prostate cancer associated transcript 18 (non-protein coding) | ||||
PCAT19 | PCAT19 | LINC01190 | prostate cancer associated transcript 19 (non-protein coding) | ||||
PCAT29 | PCAT29 | N/A | prostate cancer associated transcript 29 (non-protein coding) | ||||
PCAT5 | PCAT5 | TPCAT-10-36067 | prostate cancer associated transcript 5 (non-protein coding) | ||||
PCBP2-OT1 | PCBP2-OT1 | TUC338 | PCBP2 overlapping transcript 1 | ||||
PCBP3-OT1 | PCBP3-OT1 | FLJ44028 | PCBP3 overlapping transcript 1 | ||||
PCF11-AS1 | PCF11-AS1 | ENST00000602322.1 | PCF11 anstisense RNA 1 | ||||
PCNA-AS1 | PCNA-AS1 | N/A | PCNA antisense RNA 1 | ||||
PEG13 | PEG13 | N/A | paternally expressed 13 | ||||
PEG3-AS1 | PEG3-AS1 | APEG3, NCRNA00155 | PEG3 antisense RNA 1 | ||||
PICSAR | PICSAR | PRED74, NLC1-C | P38 inhibited cutaneous squamous cell carcinoma associated lincRNA | ||||
PINK1-AS | PINK1-AS | FLJ00387, PINK1AS, naPINK1 | PINK1 antisense RNA | ||||
PISRT1 | PISRT1 | NCRNA00195 | polled intersex syndrome regulated transcript 1 (non-protein coding RNA) | ||||
PRKCQ-AS1 | PRKCQ-AS1 | ENST00000414894.1 | PRKCQ antisense RNA 1 | ||||
PRR7-AS1 | PRR7-AS1 | N/A | PRR7 antisense RNA 1 | ||||
PSMA3-AS1 | PSMA3-AS1 | FLJ31306 | PSMA3 antisense RNA 1 | ||||
PSMD5-AS1 | PSMD5-AS1 | N/A | PSMD5 antisense RNA 1 (head to head) | ||||
PTENP1-AS | PTENP1-AS | PTENpg1-asRNA | PTENP1 antisense RNA | ||||
PTPRJ-AS1 | PTPRJ-AS1 | N/A | PTPRJ antisense RNA 1 | ||||
PWAR1 | PWAR1 | PAR1, PAR-1 | Prader Willi/Angelman region RNA 1 | ||||
PWAR4 | PWAR4 | PAR4, PAR-4 | Prader Willi/Angelman region RNA 4 | ||||
PWAR5 | PWAR5 | PAR5, PAR-5 | Prader Willi/Angelman region RNA 5 | ||||
PWARSN | PWARSN | PAR-SN, PARSN | Prader Willi/Angelman region RNA, SNRPN neighbor | ||||
RAD51-AS1 | RAD51-AS1 | TODRA | RAD51 antisense RNA 1 (head to head) | ||||
RFPL1S | RFPL1S | RFPL1-AS, NCRNA00006 | RFPL1 antisense RNA 1 | ||||
RGMB-AS1 | RGMB-AS1 | N/A | RGMB antisense RNA 1 | ||||
RHPN1-AS1 | RHPN1-AS1 | MGC3113 | RHPN1 antisense RNA 1 (head to head) | ||||
RMST | RMST | NCRMS, NCRNA00054, LINC00054 | rhabdomyosarcoma 2 associated transcript (non-protein coding) | ||||
RNF217-AS1 | RNF217-AS1 | STL | RNF217 antisense RNA 1 (head to head) | ||||
RNF219-AS1 | RNF219-AS1 | N/A | RNF219 antisense RNA 1 | ||||
RPL34-AS1 | RPL34-AS1 | FLJ37673, RP11-462C24.1 | RPL34 antisense RNA 1 (head to head) | ||||
RPS6KA2-AS1 | RPS6KA2-AS1 | N/A | RPS6KA2 antisense RNA 1 | ||||
RUSC1-AS1 | RUSC1-AS1 | FLJ35976 | RUSC1 antisense RNA 1 | ||||
SALRNA1 | SALRNA1 | SAL-RNA1, XLOCN/A023166 | senescence associated long non-coding RNA 1 | ||||
SALRNA2 | SALRNA2 | SAL-RNA2, XLOCN/A025931 | senescence associated long non-coding RNA 2 | ||||
SALRNA3 | SALRNA3 | SAL-RNA3, XLOCN/A025918 | senescence associated long non-coding RNA 3 | ||||
SAMD12-AS1 | SAMD12-AS1 | N/A | SAMD12 antisense RNA 1 | ||||
SAMMSON | SAMMSON | N/A | survival associated mitochondrial melanoma specific oncogenic non-coding RNA | ||||
SAP30L-AS1 | SAP30L-AS1 | FLJ38109, GALNT10-AS1 | SAP30L antisense RNA 1 (head to head) | ||||
SEC24B-AS1 | SEC24B-AS1 | 1/2-SBSRNA4 | SEC24B antisense RNA 1 | ||||
SGMS1-AS1 | SGMS1-AS1 | N/A | SGMS1 antisense RNA 1 | ||||
SIRT1-AS | SIRT1-AS | N/A | SIRT1 antisense RNA | ||||
SMAD1-AS1 | SMAD1-AS1 | ENST00000513542 | SMAD1 antisense RNA 1 | ||||
SMAD5-AS1 | SMAD5-AS1 | DAMS | SMAD5 antisense RNA 1 | ||||
SMCR2 | SMCR2 | N/A | Smith-Magenis syndrome chromosome region, candidate 2 (non-protein coding) | ||||
SMCR5 | SMCR5 | NCRNA00034 | Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding) | ||||
SMCR6 | SMCR6 | N/A | Smith-Magenis syndrome chromosome region, candidate 6 (non-protein coding) | ||||
SMG7-AS1 | SMG7-AS1 | DKFZP564C196 | SMG7 antisense RNA 1 | ||||
SNAI3-AS1 | SNAI3-AS1 | MGC23284 | SNAI3 antisense RNA 1 | ||||
SNHG10 | SNHG10 | FLJ40557, NCRNA00063, LINC00063 | small nucleolar RNA host gene 10 | ||||
SNHG11 | SNHG11 | LINC00101 | small nucleolar RNA host gene 11 | ||||
SNHG12 | SNHG12 | PNAS-123, LINC00100, ASLNC04080 | small nucleolar RNA host gene 12 | ||||
SNHG14 | SNHG14 | NCRNA00214, UBE3A-AS | small nucleolar RNA host gene 14 | ||||
SNHG15 | SNHG15 | FLJ38860, MYO1GUT, Linc-Myo1g | small nucleolar RNA host gene 15 | ||||
SNHG16 | NONHSAT056039 | ncRAN | small nucleolar RNA host gene 16 | ||||
SNHG20 | SNHG20 | PRO0872, FLJ25582, DKFZp686L05235, SCARNA16HG | small nucleolar RNA host gene 20 | ||||
SNHG7 | SNHG7 | MGC16037, NCRNA00061 | small nucleolar RNA host gene 7 | ||||
SNHG8 | SNHG8 | NCRNA00060, LINC00060 | small nucleolar RNA host gene 8 | ||||
SOCS2-AS1 | SOCS2-AS1 | N/A | SOCS2 antisense RNA 1 | ||||
SOX21-AS1 | SOX21-AS1 | N/A | SOX21 antisense RNA 1 (head to head) | ||||
SOX2-OT | SOX2-OT | DKFZp761J1324, NCRNA00043 | SOX2 overlapping transcript | ||||
SPATA3-AS1 | SPATA3-AS1 | N/A | SPATA3 antisense RNA 1 (head to head) | ||||
ST7-AS1 | ST7-AS1 | ST7AS1 | ST7 antisense RNA 1 | ||||
ST7-AS2 | ST7-AS2 | ST7AS2 | ST7 antisense RNA 2 | ||||
ST7-OT3 | ST7-OT3 | NCRNA00026 | ST7 overlapping transcript 3 | ||||
STAM-AS1 | STAM-AS1 | locus3182 | STAM antisense RNA 1 (head to head) | ||||
STX18-AS1 | STX18-AS1 | LOC100507266 | STX18 antisense RNA 1 (head to head) | ||||
TCL6 | TCL6 | TCL6e1, TNG2, TNG1 | T-cell leukemia/lymphoma 6 (non-protein coding) | ||||
TDRG1 | NONHSAT112472 | LINC00532, lincRNA-NRN/A024015 | testis development related 1 (non-protein coding) | ||||
TEX41 | TEX41 | DKFZp686O1327, LINC00953 | testis expressed 41 (non-protein coding) | ||||
TGFB2-OT1 | TGFB2-OT1 | FLJ11812 | TGFB2 overlapping transcript 1 | ||||
TH2LCRR | TH2LCRR | TH2-LCR | T helper type 2 locus control region associated RNA | ||||
THRIL | Lnc-DHX37-1:1 | Linc1992, TCONSN/A00020260, BRI3BP-AS1 | TNF and HNRNPL related immunoregulatory long non-coding RNA | ||||
TINCR | ENST00000448587.1 | FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16 | tissue differentiation-inducing non-protein coding RNA | ||||
TLX1NB | TLX1NB | TD1, TDI, APT-B7 | TLX1 neighbor | ||||
TMEM92-AS1 | TMEM92-AS1 | RP11-893F2.9, lncRNA-508851, TCONSN/A00025237 | TMEM92 antisense RNA 1 | ||||
TMEM9B-AS1 | TMEM9B-AS1 | N/A | TMEM9B antisense RNA 1 | ||||
TOLLIP-AS1 | TOLLIP-AS1 | N/A | TOLLIP antisense RNA 1 (head to head) | ||||
TP53COR1 | TP53COR1 | linc-p21, lincRNA-p21, Trp53cor1 | tumor protein p53 pathway corepressor 1 (non-protein coding) | ||||
TP53TG1 | TP53TG1 | HN/ARG012D21.9, LINC00096 | TP53 target 1 (non-protein coding) | ||||
TP73-AS1 | TP73-AS1 | PDAM | TP73 antisense RNA 1 | ||||
TRERNA1 | TRERNA1 | ncRNA-a7, treRNA | translation regulatory long non-coding RNA 1 | ||||
TRPM2-AS | TRPM2-AS | TRPM2-AS1 | TRPM2 antisense RNA | ||||
TSIX | TSIX | NCRNA00013, XIST-AS1, LINC00013 | TSIX transcript, XIST antisense RNA | ||||
TSPEAR-AS2 | TSPEAR-AS2 | N/A | TSPEAR antisense RNA 2 | ||||
TTC28-AS1 | TTC28-AS1 | KIAA1648 | TTC28 antisense RNA 1 | ||||
TTTY15 | TTTY15 | DKFZP434I143, NCRNA00138 | testis-specific transcript, Y-linked 15 (non-protein coding) | ||||
TTTY17A | TTTY17A | NCRNA00140 | testis-specific transcript, Y-linked 17A (non-protein coding) | ||||
TTTY3 | TTTY3 | TTY3, TTTY3A, LINC00121 | testis-specific transcript, Y-linked 3 (non-protein coding) | ||||
TTTY4 | TTTY4 | TTY4, TTTY4A, LINC00123 | testis-specific transcript, Y-linked 4 (non-protein coding) | ||||
TTTY5 | TTTY5 | TTY5, LINC00126 | testis-specific transcript, Y-linked 5 (non-protein coding) | ||||
TTTY6 | TTTY6 | TTY6, TTTY6A, LINC00127 | testis-specific transcript, Y-linked 6 (non-protein coding) | ||||
TTTY9B | TTTY9B | NCRNA00132 | testis-specific transcript, Y-linked 9B (non-protein coding) | ||||
TUNAR | TUNAR | TUNA, HI-LNC78 | TCL1 upstream neural differentiation-associated RNA | ||||
TUSC8 | TUSC8 | XLOCN/A010588 | tumor suppressor candidate 8 (non-protein coding) | ||||
UMODL1-AS1 | UMODL1-AS1 | FLJ33471 | UMODL1 antisense RNA 1 | ||||
VLDLR-AS1 | VLDLR-AS1 | N/A | VLDLR antisense RNA 1 | ||||
WAC-AS1 | WAC-AS1 | N/A | WAC antisense RNA 1 (head to head) | ||||
WASIR2 | WASIR2 | N/A | WASH and IL9R antisense RNA 2 | ||||
WDFY3-AS2 | WDFY3-AS2 | FBI4 | WDFY3 antisense RNA 2 | ||||
WSPAR | WSPAR | TCONSN/A00009511-XLOCN/A004555, lncTCF7 | WNT signaling pathway activating non-coding RNA | ||||
XACT | XACT | N/A | X active specific transcript (non-protein coding) | ||||
YAM1 | YAM1 | Yam-1 | YY1-associated myogenesis RNA 1 | ||||
ZBED3-AS1 | ZBED3-AS1 | N/A | ZBED3 antisense RNA 1 | ||||
ZEB1-AS1 | ZEB1-AS1 | N/A | ZEB1 antisense RNA 1 | ||||
ZFAT-AS1 | ZFAT-AS1 | SAS-ZFAT, NCRNA00070 | ZFAT antisense RNA 1 | ||||
ZIM2-AS1 | ZIM2-AS1 | ZIM2as | ZIM2 antisense RNA 1 | ||||
ZNF205-AS1 | ZNF205-AS1 | MGC3771 | ZNF205 antisense RNA 1 | ||||
ZNF252P-AS1 | ZNF252P-AS1 | N/A | ZNF252P antisense RNA 1 | ||||
ZNF436-AS1 | ZNF436-AS1 | FLJ90508 | ZNF436 antisense RNA 1 | ||||
ZNF582-AS1 | ZNF582-AS1 | N/A | ZNF582 antisense RNA 1 (head to head) | ||||
ZNF667-AS1 | ZNF667-AS1 | MORT | ZNF667 antisense RNA 1 (head to head) | ||||
ZRANB2-AS2 | ZRANB2-AS2 | N/A | ZRANB2 antisense RNA 2 (head to head) |